UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 3, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to    

Commission file number 1-37393

SPX FLOW, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware		47-3110748
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)
13320 Ballantyne Corporate Place		28277
Charlotte,	NC	(Zip Code)
(Address of Principal Executive Offices)

Registrant’s Telephone Number, Including Area Code (704) 752-4400

(Former Name, Former Address, and Former Fiscal Year, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, Par Value $0.01	FLOW	New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☒	Accelerated Filer	☐
Non-Accelerated Filer	☐	Smaller Reporting Company		☐
		Emerging Growth Company		☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

Common shares outstanding as of August 2, 2021 were 41,629,822.

SPX FLOW, INC. AND SUBSIDIARIES

FORM 10-Q INDEX

PART I - FINANCIAL INFORMATION
Item 1 – Condensed Consolidated Financial Statements
Condensed Consolidated Statements of Operations for the Three and Six Months Ended July 3, 2021 and June 27, 2020 (Unaudited)	1
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Six Months Ended July 3, 2021 and June 27, 2020 (Unaudited)	2
Condensed Consolidated Balance Sheets as of July 3, 2021 and December 31, 2020 (Unaudited)	3
Condensed Consolidated Statements of Equity for the Three and Six Months Ended July 3, 2021 and June 27, 2020 (Unaudited)	4
Condensed Consolidated Statements of Cash Flows for the Six Months Ended July 3, 2021 and June 27, 2020 (Unaudited)	6
Notes to Condensed Consolidated Financial Statements	8
Note 1 - Basis of Presentation	8
Note 2 - New Accounting Pronouncements	8
Note 3 - Business Acquisitions, Disposals and Discontinued Operations	9
Note 4 - Information on Reportable Segments, Corporate Expense and Other	14
Note 5 - Revenue from Contracts with Customers	15
Note 6 - Restructuring and Other Related Charges	17
Note 7 - Inventories, Net	18
Note 8 - Goodwill, Other Intangible Assets and Asset Impairment Charges	18
Note 9 - Employee Benefit Plans	20
Note 10 - Indebtedness	21
Note 11 - Derivative Financial Instruments	22
Note 12 - Equity and Stock-Based Compensation	22
Note 13 - Litigation, Contingent Liabilities and Other Matters	25
Note 14 - Income Taxes	26
Note 15 - Fair Value	27
Note 16 - Subsequent Events	30
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations	33
Item 3 – Quantitative and Qualitative Disclosures About Market Risk	46
Item 4 – Controls and Procedures	46
PART II - OTHER INFORMATION
Item 1 – Legal Proceedings	47
Item 1A – Risk Factors	47
Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds	47
Item 6 – Exhibits	47
SIGNATURES	48

PART I—FINANCIAL INFORMATION

ITEM 1. Condensed Consolidated Financial Statements

SPX FLOW, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited; in millions, except per share amounts)

	Three months ended				Six months ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Revenues	$	381.6	$	308.1	$	745.4	$	597.6
Cost of products sold	249.9		194.6		485.2		383.0
Gross profit	131.7		113.5		260.2		214.6
Selling, general and administrative	93.8		90.8		184.2		176.0
Intangible amortization	4.7		2.9		7.7		5.7
Asset impairment charges	—		0.8		—		2.7
Restructuring and other related charges	4.3		4.8		13.5		7.4
Operating income	28.9		14.2		54.8		22.8
Other income, net	2.3		5.8		8.6		4.3
Interest expense, net	(4.9)		(9.4)		(9.8)		(17.5)
Income from continuing operations before income taxes	26.3		10.6		53.6		9.6
Income tax provision	(14.7)		(3.9)		(23.0)		(3.0)
Income from continuing operations	11.6		6.7		30.6		6.6
Loss from discontinued operations, net of tax	(0.6)		(31.6)		(0.9)		(36.7)
Net income (loss)	11.0		(24.9)		29.7		(30.1)
Less: Net income attributable to noncontrolling interests	0.2		0.2		0.3		0.3
Net income (loss) attributable to SPX FLOW, Inc.	$	10.8	$	(25.1)	$	29.4	$	(30.4)
Amounts attributable to SPX FLOW, Inc. common shareholders:
Income from continuing operations, net of tax	$	11.4	$	6.5	$	30.3	$	6.2
Loss from discontinued operations, net of tax	(0.6)		(31.6)		(0.9)		(36.6)
Net income (loss) attributable to SPX FLOW, Inc.	$	10.8	$	(25.1)	$	29.4	$	(30.4)
Basic income (loss) per share of common stock:
Income per share from continuing operations	$	0.27	$	0.15	$	0.72	$	0.15
Loss per share from discontinued operations	(0.01)		(0.75)		(0.02)		(0.86)
Net income (loss) per share attributable to SPX FLOW, Inc.	0.26		(0.59)		0.70		(0.71)
Diluted income (loss) per share of common stock:
Income per share from continuing operations	$	0.27	$	0.15	$	0.72	$	0.15
Loss per share from discontinued operations	(0.01)		(0.74)		(0.02)		(0.86)
Net income (loss) per share attributable to SPX FLOW, Inc.	0.26		(0.59)		0.70		(0.71)
Weighted average number of common shares outstanding - basic	41.822		42.397		41.910		42.524
Weighted average number of common shares outstanding - diluted	41.840		42.505		41.954		42.703

The accompanying notes are an integral part of these statements.

1

SPX FLOW, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited; in millions)

	Three months ended				Six months ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Net income (loss)	$	11.0	$	(24.9)	$	29.7	$	(30.1)
Other comprehensive income (loss), net:
Net unrealized gains on qualifying cash flow hedges, net of tax provision of $0.1 in the three months ended June 27, 2020	—		0.3		—		0.2
Foreign currency translation adjustments	13.9		30.2		(25.5)		(34.6)
Other comprehensive income (loss), net	13.9		30.5		(25.5)		(34.4)
Total comprehensive income (loss)	24.9		5.6		4.2		(64.5)
Less: Total comprehensive income (loss) attributable to noncontrolling interests	0.1		0.4		0.3		(0.1)
Total comprehensive income (loss) attributable to SPX FLOW, Inc.	$	24.8	$	5.2	$	3.9	$	(64.4)

The accompanying notes are an integral part of these statements.

2

SPX FLOW, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited; in millions, except share data)

	July 3, 2021		December 31, 2020
ASSETS
Current assets:
Cash and equivalents	$	324.1	$	441.5
Accounts receivable, net	251.0		232.6
Contract assets	23.3		24.4
Inventories, net	238.6		199.3
Other current assets	39.7		27.4
Total current assets	876.7		925.2
Property, plant and equipment:
Land	22.3		22.8
Buildings and leasehold improvements	171.2		176.8
Machinery and equipment	353.4		349.1
	546.9		548.7
Accumulated depreciation	(312.8)		(320.6)
Property, plant and equipment, net	234.1		228.1
Goodwill	616.4		569.7
Intangibles, net	228.2		206.0
Other assets	176.5		169.5
TOTAL ASSETS	$	2,131.9	$	2,098.5
LIABILITIES, MEZZANINE EQUITY AND EQUITY
Current liabilities:
Accounts payable	$	178.1	$	149.1
Contract liabilities	123.8		119.5
Accrued expenses	185.7		178.7
Income taxes payable	27.6		23.0
Short-term debt	15.5		12.5
Current maturities of long-term debt	0.1		0.1
Total current liabilities	530.8		482.9
Long-term debt	397.6		397.3
Deferred and other income taxes	43.0		36.6
Other long-term liabilities	117.7		117.5
Total long-term liabilities	558.3		551.4
Commitments and contingent liabilities (Note 13)
Mezzanine equity	3.4		3.4
Equity:
SPX FLOW, Inc. shareholders’ equity:
Preferred stock, no par value, 3,000,000 shares authorized, and no shares issued and outstanding	—		—
Common stock, par value $0.01 per share, 300,000,000 shares authorized, 43,921,450 issued and 42,055,959 outstanding at July 3, 2021, and 43,394,547 issued and 42,157,504 outstanding at December 31, 2020	0.4		0.4
Paid-in capital	1,720.2		1,696.9
Accumulated deficit	(341.5)		(363.3)
Accumulated other comprehensive loss	(251.9)		(226.4)
Common stock in treasury (1,865,491 shares at July 3, 2021, and 1,237,043 shares at December 31, 2020)	(86.9)		(46.2)
Total SPX FLOW, Inc. shareholders' equity	1,040.3		1,061.4
Noncontrolling interests	(0.9)		(0.6)
Total equity	1,039.4		1,060.8
TOTAL LIABILITIES, MEZZANINE EQUITY AND EQUITY	$	2,131.9	$	2,098.5

The accompanying notes are an integral part of these statements.

3

SPX FLOW, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(Unaudited; in millions)

	Three Months Ended July 3, 2021
	Common Stock			Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Loss		Common Stock in Treasury		Total SPX FLOW, Inc. Shareholders' Equity		Noncontrolling Interests		Total Equity
	Shares Outstanding	Par
Balance at April 3, 2021	42.3	$	0.4	$	1,710.1	$	(348.5)	$	(265.9)	$	(62.5)	$	1,033.6	$	(0.4)	$	1,033.2
Net income	—	—		—		10.8		—		—		10.8		0.2		11.0
Other comprehensive income (loss), net	—	—		—		—		14.0		—		14.0		(0.1)		13.9
Stock-based compensation expense	—	—		3.0		—		—		—		3.0		—		3.0
Exercise of stock options	0.1			7.2		—		—		—		7.2		—		7.2
Restricted stock and restricted stock unit vesting, net of tax withholdings	—	—		(0.1)		—		—		0.2		0.1		—		0.1
Common stock repurchases	(0.3)	—		—		—		—		(24.6)		(24.6)		—		(24.6)
Dividends declared ($0.09 per share)	—	—		—		(3.8)		—		—		(3.8)		—		(3.8)
Purchase of noncontrolling interest	—	—		—		—		—		—		—		(0.6)		(0.6)
Balance at July 3, 2021	42.1	$	0.4	$	1,720.2	$	(341.5)	$	(251.9)	$	(86.9)	$	1,040.3	$	(0.9)	$	1,039.4

	Three months ended June 27, 2020
	Common Stock			Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Loss		Common Stock in Treasury		Total SPX FLOW, Inc. Shareholders' Equity		Noncontrolling Interests		Total Equity
	Shares Outstanding	Par
Balance at March 28, 2020	42.6	$	0.4	$	1,681.0	$	(374.5)	$	(490.8)	$	(25.7)	$	790.4	$	8.8	$	799.2
Net income (loss)	—	—		—		(25.1)		—		—		(25.1)		0.2		(24.9)
Other comprehensive income, net	—	—		—		—		30.3		—		30.3		0.2		30.5
Stock-based compensation expense	—	—		3.8		—		—		—		3.8		—		3.8
Restricted stock and restricted stock unit vesting, net of tax withholdings	0.1	—		0.1		—		—		(0.5)		(0.4)		—		(0.4)
Common stock repurchases	(0.2)	—		—		—		—		(6.2)		(6.2)		—		(6.2)
Adjustment from mezzanine equity	—	—		1.7		—		—		—		1.7		—		1.7
Disposition of discontinued operations	—	—		—		—		178.2		—		178.2		(1.2)		177.0
Balance at June 27, 2020	42.5	$	0.4	$	1,686.6	$	(399.6)	$	(282.3)	$	(32.4)	$	972.7	$	8.0	$	980.7

4

SPX FLOW, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (CONTINUED)

(Unaudited; in millions)

	Six months ended July 3, 2021
	Common Stock			Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Loss		Common Stock in Treasury		Total SPX FLOW, Inc. Shareholders' Equity		Noncontrolling Interests		Total Equity
	Shares Outstanding	Par
Balance at December 31, 2020	42.2	$	0.4	$	1,696.9	$	(363.3)	$	(226.4)	$	(46.2)	$	1,061.4	$	(0.6)	$	1,060.8
Net income	—	—		—		29.4		—		—		29.4		0.3		29.7
Other comprehensive loss, net	—	—		—		—		(25.5)		—		(25.5)		—		(25.5)
Stock-based compensation expense	—	—		5.8		—		—		—		5.8		—		5.8
Exercise of stock options	0.3	—		17.6		—		—		—		17.6		—		17.6
Restricted stock and restricted stock unit vesting, net of tax withholdings	0.1	—		(0.1)		—		—		(6.2)		(6.3)		—		(6.3)
Common stock repurchases	(0.5)	—		—		—		—		(34.5)		(34.5)		—		(34.5)
Dividends declared ($0.18 per share)	—	—		—		(7.6)		—		—		(7.6)		—		(7.6)
Purchase of noncontrolling interest	—	—		—		—		—		—		—		(0.6)		(0.6)
Balance at July 3, 2021	42.1	$	0.4	$	1,720.2	$	(341.5)	$	(251.9)	$	(86.9)	$	1,040.3	$	(0.9)	$	1,039.4

	Six months ended June 27, 2020
	Common Stock			Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Loss		Common Stock in Treasury		Total SPX FLOW, Inc. Shareholders' Equity		Noncontrolling Interests		Total Equity
	Shares Outstanding	Par
Balance at December 31, 2019	42.6	$	0.4	$	1,677.0	$	(369.2)	$	(426.5)	$	(19.3)	$	862.4	$	10.7	$	873.1
Net income (loss)	—	—		—		(30.4)		—		—		(30.4)		0.3		(30.1)
Other comprehensive loss, net	—	—		—		—		(34.0)		—		(34.0)		(0.4)		(34.4)
Stock-based compensation expense	—	—		7.8		—		—		—		7.8		—		7.8
Restricted stock and restricted stock unit vesting, net of tax withholdings	0.1	—		0.1		—		—		(6.9)		(6.8)		—		(6.8)
Common stock repurchases	(0.2)	—		—		—		—		(6.2)		(6.2)		—		(6.2)
Dividends attributable to noncontrolling interests	—	—		—		—		—		—		—		(1.4)		(1.4)
Adjustment from mezzanine equity	—	—		1.7		—		—		—		1.7		—		1.7
Disposition of discontinued operations	—	—		—		—		178.2		—		178.2		(1.2)		177.0
Balance at June 27, 2020	42.5	$	0.4	$	1,686.6	$	(399.6)	$	(282.3)	$	(32.4)	$	972.7	$	8.0	$	980.7

The accompanying notes are an integral part of these statements.

5

SPX FLOW, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; in millions)

	Six months ended
	July 3, 2021		June 27, 2020
Cash flows from (used in) operating activities:
Net income (loss)	$	29.7	$	(30.1)
Less: Loss from discontinued operations, net of tax	(0.9)		(36.7)
Income from continuing operations	30.6		6.6
Adjustments to reconcile income from continuing operations to net cash from (used in) operating activities:
Restructuring and other related charges	13.5		7.4
Asset impairment charges	—		2.7
Deferred income taxes	7.7		18.8
Depreciation and amortization	22.0		20.0
Stock-based compensation	5.8		7.0
Pension and other employee benefits	0.6		0.7
Losses (gains) on asset sales and other, net	(0.3)		0.4
Gains on changes in fair value of investment in equity security	(7.5)		(5.3)
Changes in operating assets and liabilities, net of effects from business acquisitions and discontinued operations:
Accounts receivable and other assets	(19.5)		28.3
Contract assets and liabilities, net	1.9		3.3
Inventories	(27.7)		(29.1)
Accounts payable, accrued expenses and other	14.7		(63.6)
Cash spending on restructuring actions	(7.9)		(4.7)
Net cash from (used in) continuing operations	33.9		(7.5)
Net cash used in discontinued operations	(0.7)		(6.4)
Net cash from (used in) operating activities	33.2		(13.9)
Cash flows from (used in) investing activities:
Proceeds from asset sales and other, net	0.6		0.2
Capital expenditures	(14.4)		(11.8)
Business acquisitions, net of cash acquired of $4.5, in the six months ended July 3, 2021	(102.6)		—
Net cash used in continuing operations	(116.4)		(11.6)
Net cash from discontinued operations (includes proceeds from disposition of $406.2, less cash and restricted cash disposed of $7.3, in the six months ended June 27, 2020)	—		393.4
Net cash from (used in) investing activities	(116.4)		381.8
Cash flows used in financing activities:
Borrowings under (repayments of) purchase card program, net	2.8		(4.8)
Repayments of other financing arrangements	(1.2)		(0.3)
Purchases of common stock	(34.5)		(6.2)
Minimum withholdings paid on behalf of employees for net share settlements, net	(6.3)		(6.8)
Proceeds from the exercise of employee stock options	17.6		—
Dividends paid (includes noncontrolling interests distribution of $1.2 in the six months ended June 27, 2020)	(3.8)		(1.2)
Purchase of noncontrolling interest	(0.6)		—
Net cash used in continuing operations	(26.0)		(19.3)
Net cash used in discontinued operations	—		(0.3)
Net cash used in financing activities	(26.0)		(19.6)
Change in cash, cash equivalents and restricted cash due to changes in foreign currency exchange rates	(8.2)		5.4
Net change in cash, cash equivalents and restricted cash	(117.4)		353.7
Consolidated cash, cash equivalents and restricted cash, beginning of period	441.6		303.4
Consolidated cash, cash equivalents and restricted cash, end of period	$	324.2	$	657.1

6

SPX FLOW, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(Unaudited; in millions)

	July 3, 2021		June 27, 2020
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:
Cash and cash equivalents	$	324.1	$	657.1
Restricted cash included in other current assets	0.1		—
Consolidated cash, cash equivalents and restricted cash	$	324.2	$	657.1

The accompanying notes are an integral part of these statements.

7

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited; in millions, except per share data)

(1)    BASIS OF PRESENTATION

SPX FLOW, Inc. and its consolidated subsidiaries (“SPX FLOW,” ‘‘the Company,’’ “we,” “us,” or “our”) operate in two reportable segments: the Nutrition and Health segment and the Precision Solutions segment. During the first quarter of 2021, the Company renamed its former "Food and Beverage" segment to the "Nutrition and Health" segment. During July 2021, the Company renamed its former "Industrial" segment to the "Precision Solutions" segment. Accordingly, all current and comparative period financial information for these segments has been presented as the Nutrition and Health segment and the Precision Solutions segment in this Quarterly Report on Form 10-Q. Other than the changes in name, there were no changes to the segments and there has been no change to prior period financial information of the segments. Unless otherwise indicated, amounts provided in these Notes pertain to continuing operations only and are denoted in millions of U.S. dollars. See Note 3 for information on discontinued operations and Note 4 for information on our reportable segments.

We prepared the condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim reporting. As permitted under those rules and regulations, certain footnotes or other financial information normally required by accounting principles generally accepted in the United States (“GAAP”) can be condensed or omitted. The financial statements represent our accounts after the elimination of intercompany transactions and, in our opinion, include the adjustments (consisting only of normal and recurring items) necessary for their fair presentation.

We experienced the adverse impacts of the novel coronavirus pandemic (“COVID-19” or the “COVID-19 pandemic”) beginning in the first quarter of 2020 and these adverse impacts are expected to continue, to a lesser degree, in future quarters of 2021, and possibly longer. Despite the adverse impacts, there are no indications that the COVID-19 pandemic has resulted in a material decline in the carrying value of any assets or a material change in the estimate of any contingent amounts recorded in our condensed consolidated balance sheet as of July 3, 2021. However, there is uncertainty as to the duration and overall impact of the COVID-19 pandemic, which could result in an adverse material change in a future period to the estimates we have made related to the valuation of assets and contingent amounts, which could result in the impairment of certain assets or the recognition of costs due to increases in contingent amounts.

Preparing financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Actual results could differ from these estimates. The unaudited information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements contained in our 2020 Annual Report on Form 10-K. Interim results are not necessarily indicative of full year results and the condensed consolidated financial statements may not be indicative of the Company’s future performance.

We establish actual interim closing dates using a fiscal calendar, which requires our businesses to close their books on the Saturday closest to the end of the first calendar quarter, with the second and third quarters being 91 days in length. Our fourth quarter ends on December 31. The interim closing dates for the first, second and third quarters of 2021 are April 3, July 3, and October 2, compared to the respective March 28, June 27, and September 26, 2020 dates. We had five more days in the first quarter of 2021 and will have six fewer days in the fourth quarter of 2021 than in the respective 2020 periods.

(2)    NEW ACCOUNTING PRONOUNCEMENTS

The following is a summary of new accounting pronouncements that apply or may apply to our business.

In December 2019, the Financial Accounting Standards Board (the "FASB") issued an amendment to simplify the accounting for income taxes by, among other matters, eliminating certain existing exceptions related to the general approach in Accounting Standards Codification ("ASC") 740 relating to franchise taxes, reducing complexity in the interim-period accounting for year-to-date loss limitations and changes in tax laws, and clarifying the accounting for the step-up in the tax basis of goodwill. The transition requirements are primarily prospective and the effective date is for interim and annual reporting periods beginning after December 15, 2020. The adoption of this amendment by the Company on January 1, 2021 did not have a significant impact on our condensed consolidated financial statements.

8

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

In March 2020, and as amended in January 2021, the FASB issued an amendment to provide optional guidance to ease the potential burden in accounting for reference rate reform on financial reporting in connection with the future discontinuance of the London Interbank Offered Rate (“LIBOR”). The amended guidance is designed to provide relief from the accounting analysis and impacts that may otherwise be required for modifications to agreements (e.g., loans, debt securities, derivatives, borrowings) necessitated by the reference rate reform, including providing optional expedients and exceptions if certain criteria are met. This guidance generally can be applied from March 12, 2020 through December 31, 2022. We are currently assessing the impacts of the practical expedients provided in this guidance, and which, if any, we will adopt.

(3)    BUSINESS ACQUISITIONS, DISPOSALS AND DISCONTINUED OPERATIONS

Business Acquisitions

On August 1, 2020, the Company completed the acquisition of POSI LOCK, Inc ("POSI LOCK"), a manufacturer of hydraulic and mechanical pullers used to remove certain parts from equipment in a variety of industries ranging from power transmission and light to heavy industrial applications. We purchased substantially all of the assets, including net working capital, long-term and intangible assets, and assumed certain liabilities of the business, for a cash payment of $10.0. The assets acquired and liabilities assumed in the POSI LOCK acquisition are recorded at their fair values based on expert valuations and management estimates and its results are reported in the Company's Precision Solutions segment. Goodwill and intangible assets are expected to be fully deductible for tax purposes. The pro forma effects of the acquisition of POSI LOCK were not material to our condensed consolidated results of operations for the three and six months ended June 27, 2020.

On January 18, 2021, the Company completed the acquisition of approximately 98% of the issued and outstanding shares of Plc Uutechnic Group Oyj ("UTG Mixing Group"), a public company listed on the Nasdaq Helsinki, for a cash payment of $38.0, net of cash acquired of $2.9. UTG Mixing Group is a producer of various mixing solutions for the chemical, food, metallurgical and fertilizer, environmental technology, water treatment and pharmaceuticals markets and its results are reported in the Company's Precision Solutions segment. The acquisition of UTG Mixing Group brings additional product, technology and technical expertise to the Company’s global portfolio of mixing products and process solutions, and will enable the Company to expand its sales network for existing mixer product lines and increase its European market presence with the addition of new mixer product brands. During the first quarter of 2021, the Company initiated a squeeze-out process prescribed by Finnish law pursuant to which the Company (a) acquired the remaining outstanding shares in UTG Mixing Group and (b) delisted the shares of UTG Mixing Group from the Nasdaq Helsinki. This process was finalized in the second quarter of 2021, with the remaining shares of UTG Mixing Group being delisted from the Nasdaq Helsinki effective June 1, 2021. Transaction costs related to the UTG Mixing Group acquisition were $1.2 and were recognized as a component of "Selling, General and Administrative" expense in the accompanying condensed consolidated statements of operations.

Purchase accounting related to this acquisition was substantially completed during the second quarter of 2021. The assets acquired and liabilities assumed in the UTG Mixing Group acquisition are recorded at their fair values based on expert valuations and management estimates. The excess of the purchase price over the aggregate fair values of the net assets recognized was recorded as "Goodwill" in the accompanying condensed consolidated balance sheet as of July 3, 2021. Goodwill and intangible assets are not deductible for non-U.S. tax purposes. The Company intends to make an election under Internal Revenue Code Section 338, which will treat the purchase as an asset acquisition for U.S. tax purposes. As a result, the goodwill and intangibles will be deductible for computing the U.S. tax on the earnings of non-U.S. subsidiaries.

On May 12, 2021, the Company completed the acquisition of Philadelphia Mixing Solutions, Ltd. ("Philadelphia Mixing"), a manufacturer of in-tank mixing solutions and provider of various technical services and field support, and its results are reported in the Company's Precision Solutions segment. The acquisition of Philadelphia Mixing brings additional opportunity for synergy and growth through broadening the Company's portfolio of comprehensive mixing solutions for customers in the chemical, water and wastewater, energy, and nutrition and health markets. Additionally, this acquisition will enable the Company to expand its sales network for existing mixer product lines and increase its overall market presence. We purchased substantially all of the assets, including net working capital, long-term and intangible assets, and assumed certain liabilities of the business, for a cash payment of $64.6, net of cash acquired of $1.6. The purchase price remains subject to adjustment based on a customary period of review between the Company and seller of the levels of net working capital, cash and debt, and deductions, which we expect to conclude in the third quarter of 2021. Transaction costs related to the Philadelphia Mixing acquisition were $2.1 and were recognized as a component of "Selling, General and Administrative" expense in the accompanying condensed consolidated statements of operations.

9

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

The assets acquired and liabilities assumed in the Philadelphia Mixing acquisition are recorded at their fair values based on preliminary expert valuations and management estimates, and are subject to change when these estimates are finalized. Goodwill and intangible assets related to the U.S. business are expected to be fully deductible for U.S. tax purposes. However, goodwill and intangible assets related to the non-U.S. businesses are not deductible for non-U.S. tax purposes. Additionally, the Company intends to make an election under Internal Revenue Code Section 338, which will treat the purchase of the non-U.S. subsidiaries as an asset acquisition for U.S. tax purposes. As a result, the goodwill and intangibles will be deductible for computing the U.S. tax on the earnings of non-U.S. subsidiaries.

A summary of the purchase price paid for UTG Mixing Group and Philadelphia Mixing follows:

	UTG Mixing Group As of January 18, 2021		Philadelphia Mixing As of May 12, 2021
Assets acquired:
Current assets, including cash and equivalents of $2.9 and $1.6, respectively	$	9.7	$	21.8
Property, plant and equipment	2.5		5.4
Goodwill	23.4		33.7
Intangibles	14.3		16.0
Other assets	1.6		2.9
Total assets acquired	51.5		79.8
Liabilities assumed:
Current liabilities assumed	(5.4)		(10.9)
Long-term liabilities assumed	(5.2)		(2.7)
Total liabilities assumed	(10.6)		(13.6)
Net assets acquired	$	40.9	$	66.2

Pro Forma Financial Information

The following pro forma financial information presents the combined results of operations of the Company, UTG Mixing Group and Philadelphia Mixing for the three and six months ended July 3, 2021 and June 27, 2020 as if the acquisitions had been completed on January 1, 2020. The pro forma financial information is not necessarily indicative of what the financial results would have been had the acquisitions been completed on this date. In addition, the pro forma financial information is not indicative of, nor does it purport to project, the Company's future financial results. The pro forma financial information does not give effect to any estimated and potential cost savings or other operating efficiencies that could result from the acquisitions.

	Three months ended				Six months ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Revenues	$	388.8	$	323.9	$	764.3	$	625.0
Income (loss) from continuing operations before income taxes	20.4		8.6		45.3		(1.2)
Income (loss) from continuing operations, net of tax	6.9		5.3		24.0		(2.0)

The pro forma information presented above reflects the following adjustments related to UTG Mixing Group and Philadelphia Mixing results, prior to their respective dates of acquisition:

Fair Value Adjustments - Pre-tax costs related to (i) intangible amortization expense and (ii) amortization of the increase to fair value of acquired inventories, collectively, of $2.2, $3.6, $4.9 and $7.2 are reflected in the pro forma information for the three months ended July 3, 2021 and June 27, 2020, and the six month periods then ended, respectively. Pre-tax effects related to fair value adjustments of the acquired businesses’ property, plant and equipment were not significant for the respective periods.

Acquisition-Related Costs - Pre-tax costs related to the acquisitions of $3.3 are reflected in the pro forma information for the six months ended June 27, 2020.

10

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Accounting Policy Adjustments - The primary effect of changes to accounting policies of the acquired businesses, which have been applied since their respective dates of acquisition, relates to the Company’s application of its revenue recognition policies, including primarily the accounting for certain customer contracts over time which were previously accounted for by the acquired businesses at a point in time. The effects of the application of revenue recognition and other accounting policies of the Company to the acquired businesses were not significant for any of the periods presented above.

Income Tax Considerations - Prior to its acquisition by SPX FLOW, the U.S. legal entity of Philadelphia Mixing was a qualified subchapter S subsidiary and its income (loss) was passed through to the owners of its former parent company. Under SPX FLOW's legal entity structure, the U.S. operations of Philadelphia Mixing are required to be tax-effected. In consideration of this, as well as SPX FLOW's applicable effective tax rates in the non-U.S. jurisdictions where Philadelphia Mixing operates, a blended 20.0% effective tax rate has been applied to Philadelphia Mixing's pro forma results for all periods prior to its acquisition by the Company.

Business Disposals

In November 2020, we completed the sale of a business in our Asia Pacific region, which had been included in the Precision Solutions reportable segment, to a third-party buyer for total proceeds of $4.7, net of cash disposed, which resulted in a pre-tax loss of $4.2 during the fourth quarter of 2020. During the first quarter of 2021, we substantially completed negotiations with the buyer related to the closing-date net-working-capital adjustment, which did not significantly impact our estimate of the pre-tax loss previously recorded. We finalized the agreement and paid the related purchase price adjustment in the second quarter of 2021.

Discontinued Operations

We report businesses or asset groups as discontinued operations when, among other things, we commit to a plan to divest the business or asset group, we actively begin marketing the business or asset group, and when the sale of the business or asset group is deemed probable of occurrence within the next twelve months.

On May 2, 2019, the Company announced that its Board of Directors had initiated a process to divest a substantial portion of the Company’s former Power and Energy reportable segment, excluding the Bran+Luebbe product line (collectively, the “Disposal Group”). In connection with this announcement and the continued development of the divestiture process thereafter, and in accordance with the criteria described above, we reported the Disposal Group as “held-for-sale”, and as discontinued operations, initially as of the end of our second quarter of 2019.

In November 2019, we entered into a Purchase and Sale Agreement (the “Sale Agreement”) with an affiliate of Apollo Global Management, LLC (the “Buyer”), pursuant to which the Company agreed, indirectly through certain of its subsidiaries, to sell the businesses reflected as discontinued operations in the accompanying condensed consolidated financial statements to the Buyer for a gross purchase price of $475.0 (the “Transaction”). The gross purchase price of $475.0, which included the purchase price for a business based in India, was subject to (i) reductions based upon the level of certain deductions of the Disposal Group at the closing date, and (ii) certain adjustments based upon the level of net working capital, cash and debt of the Disposal Group at the closing date. The deductions included, for example, components of the "Contract Liabilities" and certain other current and long-term liabilities of the Disposal Group, as well as deductions for budgeted but un-incurred capital expenditures and other business infrastructure costs measured over periods defined in the Sale Agreement, but in all cases which expired at the closing date.

Fiscal 2020 Discontinued Operations Developments and Sale Closure

We recorded a pre-tax loss on Disposal Group of $8.5 during our first quarter of 2020 to reduce the carrying value of the Disposal Group to our estimate of the net proceeds expected to be realized upon finalization of the purchase price with the Buyer (which was subject to a customary period of review between the parties as discussed below), less estimated costs to sell. This loss was attributable primarily to a reduction in the U.S. dollar-denominated proceeds expected to be received from the Buyer, relative to the translated U.S. dollar-equivalent carrying values of certain non-U.S. businesses of the Disposal Group, located primarily in the U.K. and Europe, due to a strengthening of the U.S. dollar against the currencies of those businesses during the first quarter of 2020.

11

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

On March 30, 2020, the Company completed the sale of substantially all Disposal Group businesses and received proceeds from the Buyer of $406.2, based on an estimate of certain adjustments to the gross purchase price as of the closing date as discussed further above and, to a lesser extent, certain fees. The consummation of the sale to the Buyer of a remaining business based in India remained subject to regulatory approvals at that time. As noted above, finalization of the purchase price with the Buyer remained subject to a customary period of review between the parties. We recorded a pre-tax loss on Disposal Group of $2.0 during our second quarter of 2020 related to estimated working capital adjustments and reflective of ongoing discussions with the Buyer at that time. The substantial portion of “Assets of Discontinued Operations” and “Liabilities of Discontinued Operations”, as well as cumulative foreign currency translation adjustment of $178.2 (previously included in the Company’s "Accumulated Other Comprehensive Loss" ("AOCL") balance) and “Noncontrolling Interests” of $1.2, which were removed from our consolidated balance sheet during the second quarter of 2020 in connection with completion of the sale, equaled the net proceeds received upon consummation of the Transaction.

During the third quarter of 2020, we finalized the levels of net working capital, cash and debt, and deductions as of the closing date with the Buyer, which resulted in an additional $1.2 pre-tax loss on Disposal Group being recorded in our third quarter of 2020. The determination of the final settlement with the Buyer involved resolution of certain estimates and judgments based on, among other items, the interpretation and application of key terms of the Sale Agreement. In addition, during our third quarter of 2020, we recorded a $0.4 pre-tax loss on Disposal Group to reduce the carrying value of the business based in India, the sale of which remained subject to regulatory approvals.

During the fourth quarter of 2020 and upon receiving relevant regulatory approvals, we completed the sale of the remaining net assets of the Disposal Group, based in India, to the Buyer for total proceeds of $6.3.

Other Sale Agreement Considerations

The Sale Agreement includes certain indemnification obligations which we believe are customary for transactions of this nature, including for certain tax obligations, to the extent such obligations relate to fiscal periods prior to the closing date and exceed amounts which were provided for in the balance sheet of the Disposal Group at closing.

Concurrent with the closing of the Transaction, the parties entered into certain ancillary agreements including, among others, a Transition Services Agreement (the “TSA”). Under the TSA, SPX FLOW provides the Buyer with certain specified services for varying periods in order to ensure an orderly transition of the business following the closing at agreed-upon prices or rates, which we believe approximate fair market value for such services. These services include, among others, certain information technology, finance and human resources services. Income from such services of $0.5 and $1.5 during the three and six months ended July 3, 2021, respectively, and of $1.5 during the three and six months ended June 27, 2020, was recognized as a component of "Other income, net".

12

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Results and Significant Non-cash Operating Items and Capital Expenditures of Discontinued Operations:

    Losses from discontinued operations for the three and six months ended July 3, 2021 and June 27, 2020 were as follows:

	Three months ended				Six months ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Revenues	$	—	$	0.7	$	—	$	111.4
Cost of products sold(1)	—		0.5		—		75.8
Gross profit	—		0.2		—		35.6
Selling, general and administrative(1)	0.3		0.8		0.3		31.5
Loss on Disposal Group(2)	—		2.0		0.4		10.5
Restructuring and other related charges	—		—		—		0.3
Operating loss	(0.3)		(2.6)		(0.7)		(6.7)
Other expense, net	—		—		—		(0.3)
Interest expense, net(3)	—		—		—		(1.6)
Loss from discontinued operations before income taxes	(0.3)		(2.6)		(0.7)		(8.6)
Income tax provision(4)	(0.3)		(29.0)		(0.2)		(28.1)
Loss from discontinued operations, net of tax	(0.6)		(31.6)		(0.9)		(36.7)
Less: Loss attributable to noncontrolling interests	—		—		—		(0.1)
Loss from discontinued operations, net of tax and noncontrolling interests	$	(0.6)	$	(31.6)	$	(0.9)	$	(36.6)

(1)During the three and six months ended June 27, 2020, there was no depreciation of property, plant and equipment or amortization of intangible assets, related to our discontinued operations, as the assets of the Disposal Group were classified as held-for-sale for the period.

(2)See previous paragraphs for further discussion regarding the loss on Disposal Group recognized during the three and six months ended June 27, 2020.

(3)In addition to any business-specific interest expense and income, the interest expense, net, of discontinued operations reflects an allocation of interest expense, including the amortization of deferred financing fees, related to the Company’s senior notes, senior credit facilities and former trade receivables financing arrangement. Interest expense related to such debt instruments and allocated to discontinued operations was $1.6 for the six months ended June 27, 2020. The allocation of the Company’s interest expense of these debt instruments was determined based on the proportional amount of average net assets of the discontinued operations to the Company’s average net assets during each period, with the Company’s average net assets determined excluding the average outstanding borrowings under such debt instruments during each period.

(4)During the three and six months ended July 3, 2021, we recorded an income tax provision of $0.3 and $0.2, respectively, on $0.3 and $0.7 of pre-tax loss from discontinued operations. This compares to an income tax provision for the three and six months ended June 27, 2020 of $29.0 and $28.1, respectively, on $2.6 and $8.6 of pre-tax loss from discontinued operations. Among other items, the income tax provision for the three months ended June 27, 2020 was impacted by income tax charges of (i) $32.1 composed of U.S. tax expense on the tax gain on sale of Disposal Group entities sold by the U.S. parent and (ii) $1.6 in reduction of the benefit to be realized through the disposition of held-for-sale assets, which were partially offset by an income tax benefit of $4.9 related to a loss for global intangible low-taxed income purposes on the sale of certain non-U.S. entities. The significant non-U.S. sales of Disposal Group entities were in locations where local law did not require any gain to be taxed or permit any loss to result in a future benefit. In addition to these, the income tax provision for the six months ended June 27, 2020 also included the effect from the first quarter of 2020 that the majority of the pre-tax loss on Disposal Group was not deductible in the various jurisdictions where the sale of the Disposal Group was to be recognized. As such, only $1.2 of tax benefit was recognized on the $8.6 pre-tax loss on Disposal Group.

The following table summarizes the significant non-cash operating items and capital expenditures reflected in cash flows of discontinued operations for the six months ended July 3, 2021 and June 27, 2020:

	Six months ended
	July 3, 2021		June 27, 2020
Loss on Disposal Group(1)	$	0.4	$	10.5
Capital expenditures	—		(5.5)
Proceeds on disposition of Disposal Group (2)	—		398.9

13

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

(1)See previous paragraphs for further discussion regarding the loss on Disposal Group recognized during the six months ended June 27, 2020.

(2)As noted above, proceeds of $406.2 were received from the Buyer during the six months ended June 27, 2020. Net of cash and restricted cash of $7.3 included in the net assets of the Disposal Group which were sold as of March 30, 2020, cash flows of $398.9 were realized upon disposition of the Disposal Group (excluding consummation of the sale of a business based in India, as noted above).

(4)    INFORMATION ON REPORTABLE SEGMENTS, CORPORATE EXPENSE AND OTHER

We innovate with customers to help feed and enhance the world by designing, delivering and servicing high-value process solutions at the heart of growing and sustaining our diverse communities with operations in over 30 countries and sales in over 140 countries around the world. The Company's product offering is concentrated in process technologies that perform mixing, blending, fluid handling, separation, thermal heat transfer and other activities that are integral to processes performed across a wide variety of nutrition, health and precision solutions markets.

In determining our reportable segments, we apply the threshold criteria of the Segment Reporting Topic of the Financial Accounting Standards Board Codification (the “Codification”) to operating income or loss of each segment before considering asset impairment charges, restructuring and other related charges, gains or losses on sales of businesses, pension and postretirement service costs and other indirect corporate expenses (including corporate stock-based compensation). This is consistent with the way our chief operating decision maker evaluates the results of each segment.

Nutrition and Health

The Nutrition and Health reportable segment operates in a regulated, global industry with customers who demand highly engineered process solutions. Key demand drivers include dairy consumption, emerging market capacity expansion, sustainability and productivity initiatives, customer product innovation and food safety. Key products for the segment include homogenizers, pumps, valves, separators and heat exchangers. We also design and assemble process systems that integrate many of these products for our customers. Key brands include APV, Gerstenberg Schroeder, Seital and Waukesha Cherry-Burrell.

Precision Solutions

The Precision Solutions reportable segment primarily serves customers in the chemical, air treatment, mining, pharmaceutical, marine, infrastructure construction, general industrial and water treatment industries. Key demand drivers of this segment are tied to macroeconomic conditions and growth in the respective end markets we serve. Key products for the segment are air dryers, filtration equipment, mixers, pumps, hydraulic technologies and heat exchangers. Key brands include Airpel, APV, Bolting Systems, Bran+Luebbe, Deltech, Hankison, Jamix, Jemaco, Johnson Pump, LIGHTNIN, Philadelphia Mixing Solutions, POSI LOCK, Power Team, Stelzer, Stone and Uutechnic.

Corporate Expense

Corporate expense generally relates to the cost of our Charlotte, North Carolina corporate headquarters and our Asia Pacific center in Shanghai, China. Corporate expense also reflects stock-based compensation costs associated with corporate employees.

14

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Reportable Segment Financial Data

Financial data for our reportable segments for the three and six months ended July 3, 2021 and June 27, 2020 were as follows:

	Three months ended				Six months ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Revenues:
Nutrition and Health	$	168.3	$	144.7	$	339.9	$	282.5
Precision Solutions	213.3		163.4		405.5		315.1
Total revenues	$	381.6	$	308.1	$	745.4	$	597.6
Income:
Nutrition and Health	$	26.4	$	19.1	$	55.0	$	38.5
Precision Solutions	23.6		19.9		45.0		29.3
Total income for reportable segments	50.0		39.0		100.0		67.8
Corporate expense	16.6		19.0		31.3		34.5
Pension and postretirement service costs	0.2		0.2		0.4		0.4
Asset impairment charges(1)	—		0.8		—		2.7
Restructuring and other related charges	4.3		4.8		13.5		7.4
Consolidated operating income	$	28.9	$	14.2	$	54.8	$	22.8

(1)Asset impairment charges of $0.8 during the three months ended June 27, 2020 resulted from management’s decision to consolidate and relocate the operations of a U.S. manufacturing facility within the Precision Solutions reportable segment to existing facilities in the U.S., as well as in our EMEA and Asia Pacific regions. Charges for the six months ended June 27, 2020 included these charges as well as asset impairment charges of $1.9 which resulted from management's decision, during the first quarter of 2020, to discontinue a product line within the Precision Solutions reportable segment.

(5)     REVENUE FROM CONTRACTS WITH CUSTOMERS

Information regarding the nature, amount, timing and uncertainty of revenue, and the related cash flows, is noted in further detail below.

Revenues Recognized Over Time

The following table provides revenues recognized over time by reportable segment for the three and six months ended July 3, 2021 and June 27, 2020:

	Three months ended				Six months ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Revenues recognized over time:
Nutrition and Health	$	80.1	$	56.1	$	151.3	$	101.1
Precision Solutions	19.3		9.7		30.8		15.7
Total revenues recognized over time	$	99.4	$	65.8	$	182.1	$	116.8

15

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Disaggregated Information about Revenues

Our aftermarket revenues generally include sales of parts and service/maintenance support, and original equipment (“OE”) revenues generally include all other revenue streams. The following tables provide disaggregated information about our OE and aftermarket revenues by reportable segment for the three and six months ended July 3, 2021 and June 27, 2020:

	Three months ended July 3, 2021						Three months ended June 27, 2020
	Original Equipment		Aftermarket		Total Revenues		Original Equipment		Aftermarket		Total Revenues
Nutrition and Health	$	109.8	$	58.5	$	168.3	$	89.2	$	55.5	$	144.7
Precision Solutions	145.8		67.5		213.3		104.0		59.4		163.4
Total revenues	$	255.6	$	126.0	$	381.6	$	193.2	$	114.9	$	308.1

	Six months ended July 3, 2021						Six months ended June 27, 2020
	Original Equipment		Aftermarket		Total Revenues		Original Equipment		Aftermarket		Total Revenues
Nutrition and Health	$	216.8	$	123.1	$	339.9	$	170.0	$	112.5	$	282.5
Precision Solutions	274.7		130.8		405.5		198.9		116.2		315.1
Total revenues	$	491.5	$	253.9	$	745.4	$	368.9	$	228.7	$	597.6

Contract Balances

Our contract accounts receivable, assets and liabilities, and changes in such balances, were as follows:

	July 3, 2021		December 31, 2020		Change(1)
Contract accounts receivable(2)	$	242.0	$	219.8	$	22.2
Contract assets	23.3		24.4		(1.1)
Contract liabilities	(123.8)		(119.5)		(4.3)
Net contract balance	$	141.5	$	124.7	$	16.8

(1)    The $16.8 increase in our net contract balance from December 31, 2020 to July 3, 2021 was primarily due to (i) an increase in volume of revenues recognized at a point in time, partially due to the reduced adverse effects of the COVID-19 pandemic on the business during the six months ended July 3, 2021, (ii) the timing of advance and milestone payments received on certain Nutrition and Health contracts recognized over time, and of performance obligations satisfied and the related revenue recognized on such contracts, and (iii) an increase in net contract balance related to the acquisitions of UTG Mixing Group and Philadelphia Mixing during the six months ended July 3, 2021.

(2)     Included in “Accounts receivable, net” in our condensed consolidated balance sheets. Amounts are presented before consideration of the allowance for uncollectible accounts.

During the three months ended July 3, 2021 and June 27, 2020, we recognized revenues of $26.8 and $28.1 related to contract liabilities outstanding as of December 31, 2020 and 2019, respectively. During the six months ended July 3, 2021 and June 27, 2020, we recognized revenues of $75.0 and $70.6 related to contract liabilities outstanding as of December 31, 2020 and 2019, respectively.

Contract Costs

As of July 3, 2021 and December 31, 2020, the Company recognized an asset related to the incremental costs of obtaining contracts with customers of $0.4, which is classified in “Other current assets” in the accompanying condensed consolidated balance sheets.

Remaining Performance Obligations

As of July 3, 2021 and June 27, 2020, the aggregate amount of our remaining performance obligations was $608.5 and $546.3, respectively. The Company expects to recognize revenue on approximately 93% and substantially all of our remaining performance obligations outstanding as of July 3, 2021 within the next 12 and 24 months, respectively.

16

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

(6)     RESTRUCTURING AND OTHER RELATED CHARGES

Fiscal 2021 Global Cost Productivity Program

In February 2021, we announced a global cost productivity program focused primarily on a reduction of our "Selling, general and administrative" ("SG&A") costs. The intent of this productivity initiative is to reduce our overall cost of doing business, including a plan to achieve $30.0 of annualized SG&A cost savings by the end of 2022 while simultaneously realigning our cost structure to support profitable growth. In connection with this program, we incurred $4.3 and $13.5 of restructuring and other related charges during the three and six months ended July 3, 2021, respectively. Such charges related primarily to severance and other costs associated with commercial, engineering, and certain operational employees across both segments and across each region in which our segments operate, as well as certain functional support employees across most of our corporate functions.

Restructuring and other related charges for the three and six months ended July 3, 2021 and June 27, 2020 were as follows:

	Three months ended				Six months ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Nutrition and Health	$	2.6	$	1.5	$	5.3	$	2.0
Precision Solutions	1.1		2.8		5.1		4.6
Other	0.6		0.5		3.1		0.8
Total	$	4.3	$	4.8	$	13.5	$	7.4

Restructuring and Other Related Charges By Reportable Segment

Nutrition and Health — Charges for the three and six months ended July 3, 2021 related primarily to costs associated with the global restructuring program described above.

Charges for the three months ended June 27, 2020 related primarily to severance and other costs associated with a reduction in force of certain commercial employees based in our EMEA region. Charges for the six months ended June 27, 2020 related primarily to the above costs and, to a lesser extent, severance and other costs associated primarily with reductions in force of certain engineering, commercial and other functional support employees within the segment, across all regions in which the segment operates.

Precision Solutions — Charges for the three and six months ended July 3, 2021 related primarily to costs associated with the global restructuring program described above.

Charges for the three months ended June 27, 2020 related primarily to severance and other costs associated with (1) the consolidation and relocation of the operations of a U.S. manufacturing facility to existing facilities in the U.S. as well as in our EMEA and Asia Pacific regions, (2) a reduction in force of certain commercial employees based in our EMEA region, (3) a reduction in force of certain functional support employees based primarily in EMEA, and (4) the closure of a legal entity based in Angola.

Charges for the six months ended June 27, 2020 related to the above costs as well as severance and other costs associated primarily with reductions in force of certain engineering, commercial, and other functional support employees within the segment, across all regions in which the segment operates.

Other — Charges for the three and six months ended July 3, 2021 related primarily to costs associated with the global restructuring program described above.

Charges for the three months ended June 27, 2020 related primarily to severance costs associated with certain corporate functional support employees. Charges for the six months ended June 27, 2020 related to the above costs as well as severance and other costs associated with the rationalization of certain corporate support functions.

17

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

The following is an analysis of our restructuring liabilities (included in “Accrued expenses” in our condensed consolidated balance sheets) for the six months ended July 3, 2021 and June 27, 2020:

	Six months ended
	July 3, 2021		June 27, 2020
Balance at beginning of year	$	7.3	$	7.6
Restructuring and other related charges(1)	13.1		7.1
Balance assumed in business acquisitions	0.2		—
Utilization — cash	(7.9)		(4.7)
Currency translation adjustment and other	(0.1)		0.5
Balance at end of period	$	12.6	$	10.5

(1)Amounts that impacted restructuring and other related charges but not the restructuring liabilities included $0.4 and $0.3 for the six months ended July 3, 2021 and June 27, 2020, respectively.

(7)    INVENTORIES, NET

Inventories at July 3, 2021 and December 31, 2020 comprised the following:

	July 3, 2021		December 31, 2020
Finished goods	$	93.4	$	86.1
Work in process	50.1		39.1
Raw materials and purchased parts	102.9		81.9
Total FIFO cost	246.4		207.1
Excess of FIFO cost over LIFO inventory value	(7.8)		(7.8)
Total inventories	$	238.6	$	199.3

Inventories include material, labor and factory overhead costs and are reduced, when necessary, to estimated net realizable values. Certain domestic inventories are valued using the last-in, first-out (“LIFO”) method. These inventories were approximately 12% and 11% of total inventory at July 3, 2021 and December 31, 2020, respectively. Other inventories are valued using the first-in, first-out (“FIFO”) method.

(8)    GOODWILL, OTHER INTANGIBLE ASSETS AND ASSET IMPAIRMENT CHARGES

Goodwill

The changes in the carrying amount of goodwill by reportable segment during the six months ended July 3, 2021 were as follows:

	December 31, 2020		Goodwill Resulting from Business Combinations(1)		Impairments		Foreign Currency Translation and Other		July 3, 2021
Nutrition and Health	$	270.2	$	—	$	—	$	(6.8)	$	263.4
Precision Solutions(2)	299.5		57.1		—		(3.6)		353.0
Total	$	569.7	$	57.1	$	—	$	(10.4)	$	616.4

(1)Reflects goodwill that arose from the acquisitions of UTG Mixing Group and Philadelphia Mixing during the six months ended July 3, 2021. See Note 3 for further discussion regarding the status of estimates of the fair values of assets acquired and liabilities assumed as of July 3, 2021 in connection with these acquisitions.

(2)The carrying amount of goodwill included $134.3 and $134.6 of accumulated impairments as of July 3, 2021 and December 31, 2020, respectively.

18

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

We completed our annual impairment testing of goodwill (and indefinite-lived intangible assets that are not amortized) during the fourth quarter of 2020. The annual goodwill impairment tests indicated significant excess fair value over the carrying value of both of our reporting units. In consideration of (i) the order trends, business performance and operating results of our reporting units during the second quarter of 2021, as well as (ii) generally favorable global developments associated with the COVID-19 pandemic during the first half of 2021, we do not expect the ongoing adverse impacts of the COVID-19 pandemic to have significantly affected the assumptions underlying our long-term revenue and cash flow growth rates, operating models or business strategies that comprised the assumptions utilized in our fourth quarter of 2020 annual impairment tests.

We will continue to monitor the effects of the COVID-19 pandemic on our business in future periods in order to evaluate whether a triggering event has occurred, including evaluating the assumptions utilized in our fourth quarter of 2020 annual impairment testing. Should those conclusions continue to apply throughout the remaining fiscal quarters of 2021, we will perform our annual impairment testing of goodwill (and indefinite-lived intangible assets that are not amortized), during the fourth quarter of 2021 in conjunction with our annual financial planning process. In performing that annual impairment testing, we will assess, among other items, the effects of the COVID-19 pandemic, order trends and the operating cash flow performance of our reporting units.

Other Intangibles, Net

Identifiable intangible assets were as follows:

	July 3, 2021						December 31, 2020
	Gross Carrying Value		Accumulated Amortization		Net Carrying Value		Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Intangible assets with determinable lives:
Customer relationships	$	140.1	$	(111.3)	$	28.8	$	131.1	$	(108.5)	$	22.6
Technology	71.7		(52.9)		18.8		65.8		(52.4)		13.4
Patents	5.4		(4.7)		0.7		5.5		(4.6)		0.9
Other	12.6		(8.5)		4.1		8.7		(8.7)		—
	229.8		(177.4)		52.4		211.1		(174.2)		36.9
Trademarks with indefinite lives	175.8		—		175.8		169.1		—		169.1
Total	$	405.6	$	(177.4)	$	228.2	$	380.2	$	(174.2)	$	206.0

As of July 3, 2021, the net carrying value of intangible assets with determinable lives consisted of the following by reportable segment: $17.5 in Nutrition and Health and $34.9 in Precision Solutions. Trademarks with indefinite lives consisted of the following by reportable segment: $101.4 in Nutrition and Health and $74.4 in Precision Solutions.

As of July 3, 2021, the gross carrying values of identifiable intangible assets acquired in connection with the UTG Mixing Group and Philadelphia Mixing acquisitions consummated during the first half of 2021 included customer relationships of $11.4, technology of $7.4, other intangibles with determinable lives of $5.1 (consisting of backlog and noncompete agreements), and trademarks of $6.4. See Note 3 for further discussion regarding the status of our estimates of the fair values of identifiable intangible assets as of July 3, 2021 related to these acquisitions.

No intangible asset impairment charges were recorded during the six months ended July 3, 2021 or June 27, 2020. Other changes in the gross carrying values of trademarks and other identifiable intangible assets during the six months ended July 3, 2021 related to foreign currency translation.

19

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Tangible Long-Lived Asset Impairment Charges

As discussed in Note 4, asset impairment charges of $0.8 during the three months ended June 27, 2020 resulted from management's decision to consolidate and relocate the operations of a U.S. manufacturing facility within the Precision Solutions reportable segment to existing facilities in the U.S. as well as in our EMEA and Asia Pacific regions. Such charges related to the real property and, to a lesser extent, certain machinery and equipment of the facility. Charges for the six months ended June 27, 2020 include these charges as well as asset impairment charges of $1.9 incurred during the first quarter of 2020 which resulted from management's decision to discontinue a product line within the Precision Solutions reportable segment. Such charges related to certain machinery and equipment of the segment. No asset impairment charges were recorded during the three or six months ended July 3, 2021.

(9)    EMPLOYEE BENEFIT PLANS

SPX FLOW sponsors a number of defined benefit pension plans and a postretirement plan. For all of these plans, changes in the fair value of plan assets and actuarial gains and losses are recognized to earnings in the fourth quarter of each year, unless earlier remeasurement is required. The remaining components of pension and postretirement expense, primarily service and interest costs and expected return on plan assets, are recorded on a quarterly basis.

Components of Net Periodic Pension and Postretirement Benefit Expense

Net periodic benefit expense for our foreign pension plans and our domestic pension and postretirement plans for the three and six months ended July 3, 2021 and June 27, 2020 included the following components:

	Foreign Pension Plans				Domestic Pension and Postretirement Plans				Total				Statement of Operations Caption in Which Expense is Reported
	Three months ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Service cost	$	0.2	0.2		$	—	$	—	$	0.2	$	0.2	Selling, general and administrative
Interest cost	—		0.1		0.1		—		0.1		0.1		Other income, net
Total net periodic benefit expense	$	0.2	$	0.3	$	0.1	$	—	$	0.3	$	0.3

	Foreign Pension Plans				Domestic Pension and Postretirement Plans				Total				Statement of Operations Caption in Which Expense is Reported
	Six Months Ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Service cost	$	0.4	0.4		$	—	$	—	$	0.4	$	0.4	Selling, general and administrative
Interest cost	—		0.2		0.2		0.1		0.2		0.3		Other income, net
Total net periodic benefit expense	$	0.4	$	0.6	$	0.2	$	0.1	$	0.6	$	0.7

20

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

(10)    INDEBTEDNESS

Debt at July 3, 2021 and December 31, 2020 was comprised of the following:

	July 3, 2021		December 31, 2020
Term loan, due in June 2022	$	100.0	$	100.0
5.875% senior notes, due in August 2026	300.0		300.0
Other indebtedness(1)	16.0		13.0
Less: deferred financing fees(2)	(2.8)		(3.1)
Total debt	413.2		409.9
Less: short-term debt	15.5		12.5
Less: current maturities of long-term debt	0.1		0.1
Total long-term debt	$	397.6	$	397.3

(1)Primarily includes finance lease obligations of $0.5 and $0.5 and balances under a purchase card program of $15.3 and $12.5 as of July 3, 2021 and December 31, 2020, respectively. The purchase card program allows for payment beyond customary payment terms for goods and services acquired under the program. As this arrangement extends the payment of these purchases beyond their normal payment terms through third-party lending institutions, we have classified these amounts as short-term debt.

(2)Deferred financing fees were comprised of fees related to the term loan and senior notes.

A detailed description of our senior credit facilities and senior notes is included in our consolidated financial statements included in our 2020 Annual Report on Form 10-K.

The interest rate of outstanding borrowings under our term loan, due June 2022, was approximately 1.5% at July 3, 2021 and December 31, 2020.

At July 3, 2021, we had $494.7 of borrowing capacity under our revolving credit facilities after giving effect to $5.3 reserved for outstanding letters of credit. In addition, at July 3, 2021, we had $98.8 of available issuance capacity under our foreign credit instrument facilities after giving effect to $51.2 reserved for outstanding bank guarantees. In addition, we had $2.1 of bank guarantees outstanding under the senior credit facilities that, once satisfied, cannot be reissued.

At July 3, 2021, in addition to the revolving lines of credit described above, we had approximately $6.0 of letters of credit outstanding under separate arrangements in China and India.

Certain of our current and future debt and derivative financial instruments have, or in the future, could have interest rates that are tied to reference rates, such as LIBOR. The volatility and availability of such reference rates, including establishment of alternative reference rates, is out of our control. Changes to or the unavailability of such rates or the manner for calculation of such reference rates, could result in increases to the cost of our debt.

At July 3, 2021, we were in compliance with all covenants of our senior credit facilities and senior notes.

See Note 16 for information regarding certain subsequent events impacting the Company's indebtedness, including (i) our notification to bondholders of our irrevocable intent to redeem the full principal amount of our senior notes during the third quarter of 2021, and (ii) an amendment to our senior credit facilities executed during the third quarter of 2021.

21

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

(11)    DERIVATIVE FINANCIAL INSTRUMENTS

We manufacture and sell our products in a number of countries and, as a result, are exposed to movements in foreign currency (“FX”) exchange rates. Our objective is to preserve the economic value of non-functional currency-denominated cash flows and to minimize the impact of changes as a result of currency fluctuations. Our principal currency exposures relate to the Euro, Chinese Yuan and British Pound.

We had FX forward contracts with an aggregate notional amount of $34.3 and $40.7 outstanding as of July 3, 2021 and December 31, 2020, respectively, with all such contracts scheduled to mature within one year. We also had FX embedded derivatives with an aggregate notional amount of $0.2 and $5.5 at July 3, 2021 and December 31, 2020, respectively, with all such contracts scheduled to mature within one year. There were no unrealized gains or losses recorded in accumulated other comprehensive loss related to FX forward contracts as of July 3, 2021 and December 31, 2020. The net losses recorded in “Other income, net” related to FX losses totaled $0.5 and $1.0 for the three months ended July 3, 2021 and June 27, 2020, respectively, and $0.6 and $1.8 for the six months then ended.

We enter into arrangements designed to provide the right of setoff in the event of counterparty default or insolvency, and have elected to offset the fair values of our FX forward contracts in our condensed consolidated balance sheets. The gross fair values of our FX forward contracts and FX embedded derivatives, in aggregate, were $0.0 and $0.2 (gross assets) and $0.0 and $0.0 (gross liabilities) at July 3, 2021 and December 31, 2020, respectively.

(12)    EQUITY AND STOCK-BASED COMPENSATION

Income (Loss) Per Share

The following table sets forth the number of weighted-average shares outstanding used in the computation of basic and diluted income (loss) per share:

	Three months ended		Six months ended
	July 3, 2021	June 27, 2020	July 3, 2021	June 27, 2020
Weighted-average shares outstanding, basic	41.822	42.397	41.910	42.524
Dilutive effect of share-based awards	0.018	0.108	0.044	0.179
Weighted-average shares outstanding, dilutive(1)	41.840	42.505	41.954	42.703

(1)Unvested restricted stock shares/units not included in the computation of diluted income per share because required market thresholds for vesting (as discussed below) were not met, were 0.000 and 0.154 for the three months ended July 3, 2021 and June 27, 2020, respectively, and 0.000 and 0.123 for the six months then ended, respectively. Unvested restricted stock shares/units not included in the computation of diluted income per share because required internal performance thresholds for vesting (as discussed below) were not met, were 0.070 and 0.215 for the three months ended July 3, 2021 and June 27, 2020, respectively, and 0.070 and 0.193 for the six months then ended, respectively. Stock options outstanding excluded from the computation of diluted income per share because their exercise price was greater than the average market price of common shares were 0.342 for the three and six months ended June 27, 2020, respectively. No stock options outstanding were excluded from the computation of diluted income per share for the three and six months ended July 3, 2021.

Stock-Based Compensation

SPX FLOW stock-based compensation awards may be granted to certain eligible employees or non-employee directors under the SPX FLOW Stock Compensation Plan (the “Stock Plan”). Under the Stock Plan, up to 1.763 unissued shares of our common stock were available for future grant as of July 3, 2021. The Stock Plan permits the issuance of authorized but unissued shares or shares from treasury upon the vesting of restricted stock units, granting of restricted stock shares or exercise of stock options. Each restricted stock share, restricted stock unit and stock option granted reduces share availability under the Stock Plan by one share.

Restricted stock shares or restricted stock units may be granted to certain eligible employees or non-employee directors in accordance with the Stock Plan and applicable award agreements. Subject to participants' continued service and other award terms and conditions, the restrictions lapse and awards generally vest over a period of time, generally three years (or one year for awards to non-employee directors). In some instances, such as death, disability, or retirement, awards may vest concurrently with or following an employee's termination. Approximately half of such restricted stock shares and restricted stock unit awards vest based on performance thresholds, while the remaining portion vest based on the passage of time since grant date.

22

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Eligible employees, including officers, were granted 2021 target performance awards, primarily during the three months ended April 3, 2021, that vest subject to attainment of certain performance vesting criteria. Such awards are generally subject to the employees’ continued employment during the three-year vesting period, and may be completely forfeited if the threshold performance criteria are not met. Vesting for the 2021 target performance awards is based on SPX FLOW shareholder return versus the performance of a composite group of companies, as established under the awards (the “Composite Group”), over the three-year period from January 1, 2021 through December 31, 2023. In the event of vesting, the 2021 target performance awards based on shareholder return performance generally restrict the recipient from selling, transferring, pledging or assigning the underlying shares for a one-year period, ending December 31, 2024, other than for tax withholding. These target performance awards were issued as restricted stock units to eligible employees, including officers.

In addition, certain eligible employees, including officers, were granted 2021 target performance awards primarily during the three months ended April 3, 2021 that vest subject to attainment of stated operating income margin threshold (as defined under the awards) measured at the conclusion of the measurement period ending December 31, 2023 (including eligible employees’ continued employment during the measurement period). These target performance awards were issued as restricted stock units to eligible employees, including officers.

Eligible employees, including officers, also were granted 2021 awards, primarily during the three months ended April 3, 2021, that vest ratably over three years, subject to the passage of time and the employees’ continued employment during such period. In some instances, such as death, disability, or retirement, awards may vest concurrently with or following an employee's termination. These awards were issued as restricted stock units to eligible employees, including officers.

In accordance with terms of the Sale Agreement entered into with the Buyer, all awards granted to SPX FLOW employees who became employees of the Buyer upon closing of the Transaction on March 30, 2020, and that vest subject to the passage of time and the employees’ continued employment that would have otherwise vested within the twelve-month period following the closing date of the Transaction, vested as of March 30, 2020. Target performance awards granted in 2017 to such employees that vest subject to (i) SPX FLOW shareholder return versus the Composite Group or (ii) attainment of stated improvements in the three-year average annual return on invested capital, vested according to the terms of the underlying award agreements (including continued employment during the measurement period). All other outstanding share-based awards to SPX FLOW employees who became employees of the Buyer that did not vest under these conditions, were forfeited as of March 30, 2020.

Restricted stock unit awards granted to eligible employees, including officers, primarily during the three months ended April 3, 2021, include early retirement provisions which permit recipients to be eligible for vesting generally upon reaching the age of 60 and completing ten years of service (and, if applicable, subject to the attainment of performance measures).

Restricted stock units that do not vest within the applicable vesting period are forfeited.

Stock options may be granted to eligible employees in the form of incentive stock options or nonqualified stock options. The option price per share may be no less than the fair market value of our common stock at the close of business on the date of grant. Upon exercise, the employee has the option to surrender previously owned shares at current value in payment of the exercise price and/or for withholding tax obligations.

The recognition of compensation expense for share-based awards is based on their grant-date fair values. The fair value of each award is amortized over the lesser of the award's requisite or derived service period, which is generally up to three years as noted above. For the three and six months ended July 3, 2021 and June 27, 2020, we recognized compensation expense related to share-based programs in “Selling, general and administrative” expense in the accompanying condensed consolidated statements of operations as follows:

23

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

	Three months ended				Six months ended
	July 3, 2021		June 27, 2020		July 3, 2021		June 27, 2020
Stock-based compensation expense - continuing and discontinued operations	$	3.0	$	3.8	5.8		7.8
Less: stock-based compensation expense recognized in discontinued operations	—		—		—		0.8
Stock-based compensation expense recognized in continuing operations	3.0		3.8		5.8		7.0
Income tax benefit	(0.6)		(0.8)		(1.0)		(1.6)
Stock-based compensation expense, net of income tax benefit	$	2.4	$	3.0	$	4.8	$	5.4

Restricted Stock Unit Awards

The Monte Carlo simulation model valuation technique was used to determine the fair value of our 2021 restricted stock units that contain a “market condition.” The Monte Carlo simulation model utilizes multiple input variables that determine the probability of satisfying the market condition stipulated in the award and calculates the fair value of each restricted stock unit award. The valuation of such 2021 awards also reflects an illiquidity discount of 14.6%, determined utilizing the Chafee model valuation technique, and related to the one-year period that recipients are restricted from selling, transferring, pledging or assigning the underlying shares, in the event of vesting and as discussed above.

The following table summarizes the unvested restricted stock share and restricted stock unit activity for the six months ended July 3, 2021:

	Unvested Restricted Stock Shares and Restricted Stock Units	Weighted-Average Grant-Date Fair Value Per Share
Outstanding at December 31, 2020	0.931	$37.03
Granted	0.322	66.99
Vested	(0.292)	39.61
Forfeited and other	(0.154)	43.40
Outstanding at July 3, 2021	0.807	$46.84

As of July 3, 2021, there was $27.8 of unrecognized compensation cost related to restricted stock share and restricted stock unit compensation arrangements. We expect this cost to be recognized over a weighted-average period of 2.1 years.

Stock Options

There were 0.016 and 0.301 of SPX FLOW stock options outstanding as of July 3, 2021 and December 31, 2020, respectively, all of which were exercisable as of July 3, 2021 and December 31, 2020. The decrease in the first six months of 2021 was due to stock options exercised during the period. The weighted-average exercise price per share of the stock options is $61.29 and the weighted-average grant-date fair value per share is $19.33. The term of these options expires on January 2, 2025 (subject to earlier expiration upon a recipient's termination of service as provided under the awards). There was no unrecognized compensation cost related to these stock options as of July 3, 2021.

Accumulated Other Comprehensive Loss

Substantially all of accumulated other comprehensive loss (“AOCL”) as of July 3, 2021 and December 31, 2020 was foreign currency translation adjustment. See the condensed consolidated statements of comprehensive income (loss) for changes in AOCL for the three and six months ended July 3, 2021 and June 27, 2020, and Note 3 for further discussion regarding amounts reclassified out of AOCL during the three and six months ended June 27, 2020 in connection with the disposition of the Disposal Group.

24

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Common Stock in Treasury

    During the six months ended July 3, 2021 and June 27, 2020, “Common stock in treasury” was increased by $6.2 and $6.9, respectively, for common stock that was surrendered by recipients of restricted stock as a means of funding the related applicable income tax withholding requirements.

During the three and six months ended July 3, 2021, we repurchased 0.373 and 0.531 shares of our common stock for cash consideration of $24.6 and $34.5, respectively, in accordance with a share repurchase program authorized by our Board of Directors for the purchase of up to $150.0 shares of our common stock on or before December 31, 2021. As of July 3, 2021, there remained approximately $95.6 in shares available to be purchased by the Company under the share repurchase program.

Dividends

On March 10, 2021, we announced the declaration of a quarterly dividend on our common stock of $0.09 per share, paid on April 14, 2021 to stockholders of record as of the close of business on March 24, 2021. On June 17, 2021, we announced the declaration of a quarterly dividend on our common stock of $0.09 per share, paid on July 14, 2021 to stockholders of record as of the close of business on June 30, 2021. The accrual of the dividend payable of $3.8 is reflected in "Accrued expenses" in our accompanying condensed consolidated balance sheet as of July 3, 2021.

Noncontrolling Interests

During the second quarter of 2021, the Company executed an agreement with noncontrolling interest shareholders in a joint venture wherein the Company acquired all outstanding noncontrolling shares for $0.6 in cash. The noncontrolling interest was reduced by the consideration paid for these shares during the three months ended July 3, 2021.

(13)    LITIGATION, CONTINGENT LIABILITIES AND OTHER MATTERS

Various claims, complaints and proceedings arising in the ordinary course of business, including those relating to litigation matters (e.g., class actions, derivative lawsuits and contracts, intellectual property and competitive claims, and claims to certain indemnification obligations arising from previous acquisitions/dispositions), have been filed or are pending against us and certain of our subsidiaries. We believe these matters are either without merit or of a kind that should not have a material effect, individually or in the aggregate, on our financial position, results of operations or cash flows.

We are subject to domestic and international environmental protection laws and regulations with respect to our business operations and are operating in compliance with, or taking action aimed at ensuring compliance with, these laws and regulations. We believe our compliance obligations with environmental protection laws and regulations should not have a material effect, individually or in the aggregate, on our financial position, results of operations or cash flows.

Mezzanine Equity

Independent noncontrolling shareholders in certain foreign subsidiaries of the Company have put options under their respective joint venture operating agreements that allow them to sell their common stock to the controlling shareholders (wholly-owned subsidiaries of SPX FLOW) upon the satisfaction of certain conditions, including the passage of time. The respective carrying values presented in “Mezzanine equity” of our condensed consolidated balance sheets as of July 3, 2021 and December 31, 2020 are stated at the current exercise value of the put options, irrespective of whether the options are currently exercisable. To the extent the noncontrolling interests' put option price is correlated with the estimated fair value of the subsidiary, we have used the market method to estimate such fair values. This represents a Level 3 fair value measurement as described in Note 15.

During the first quarter of 2020, the noncontrolling interest shareholder of a joint venture exercised certain put options and, during the third quarter of 2020, the Company and such shareholder reached an agreement for the Company to purchase all noncontrolling interest shares in that joint venture at an agreed-upon price. In accordance with the agreement, we paid $15.0 during the year ended December 31, 2020 to purchase the shares. In connection with the share purchase of $15.0, we reduced “Noncontrolling interests” by $7.7 to reflect the reduction in the noncontrolling shareholder’s cumulative carrying value of ownership interest in the joint venture during 2020, with the remainder of the purchase price paid reflected as a reduction of “Paid-in capital”. In addition, as a result of the share purchase during the year ended December 31, 2020, we reflected the settlement of the related put options during the year as a reduction of “Mezzanine equity” of $15.0, with an increase of “Paid-in capital”.

25

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

We have $3.4 of current exercise value of put options outstanding as of July 3, 2021 and December 31, 2020 related to a different foreign subsidiary than that discussed above and all of which became exercisable during 2020. The carrying value of such put options is recorded based on our best estimate of the ultimate redemption value of the put options. If and when such options are exercised, we expect to settle the option value in cash.

(14)    INCOME TAXES

Unrecognized Tax Benefits

As of July 3, 2021, we had gross unrecognized tax benefits of $17.0 (net unrecognized tax benefits of $16.1), of which $11.0, if recognized, would impact our effective tax rate from continuing operations.

We classify interest and penalties related to unrecognized tax benefits as a component of our income tax provision. As of July 3, 2021, gross accrued interest totaled $1.1 (net accrued interest of $1.0), and there was no accrual for penalties included in our unrecognized tax benefits.

Based on the outcome of certain examinations or as a result of the expiration of statutes of limitations for certain jurisdictions, we believe that within the next 12 months it is reasonably possible that our previously unrecognized tax benefits could decrease by $0.5 to $1.0. The previously unrecognized tax benefits relate to transfer pricing matters.

The unrecognized tax benefits described above represent amounts that were included in tax returns filed by the Company. Historically, a portion of the Company's operations were included in tax returns filed by SPX Corporation (the “former Parent”) or its subsidiaries that were not part of our spin-off from the former Parent effected on September 26, 2015 (the “Spin-Off”). As a result, some uncertain tax positions related to the Company's operations resulted in unrecognized tax benefits that are now potential obligations of the former Parent or its subsidiaries that were part of the Spin-Off. In addition, some of the Company's tax returns included the operations of the former Parent's subsidiaries that were not part of the Spin-Off. In certain of these cases, these subsidiaries' activities gave rise to unrecognized tax benefits for which the Company could be potentially liable. When required under the Income Taxes Topic of the Codification, we have recorded a liability for these uncertain tax positions within our condensed consolidated balance sheets.

Other Tax Matters

During the three months ended July 3, 2021, we recorded an income tax provision of $14.7 on $26.3 of pre-tax income, resulting in an effective tax rate of 55.9%. This compares to an income tax provision for the three months ended June 27, 2020 of $3.9 on $10.6 of pre-tax income, resulting in an effective tax rate of 36.8%. The effective tax rate for the second quarter of 2021 was impacted by income tax charges of (i) $4.5 resulting from the disallowance of tax year 2020 interest deductions pursuant to the German Act Implementing the EU Anti-Tax Avoidance Directive, enacted June 30, 2021, (ii) $1.8 resulting from losses occurring in the quarter in certain jurisdictions where the benefit of those losses is not expected to be realized, and (iii) $1.0 related to transfer pricing adjustments.

The effective tax rate for the second quarter of 2020 was impacted by income tax charges of (i) $6.0 resulting from losses occurring in the quarter in certain jurisdictions where the tax benefit of those losses is not expected to be realized and (ii) $1.6 related to the change in valuation allowance related to certain jurisdictions where the benefit of losses are no longer expected to be realized, which were partially offset by an income tax benefit of $7.2 resulting from adjustments to the deemed repatriation tax and certain additional foreign credits from the recharacterization of a prior outbound transfer of an affiliate to non-U.S. entities.

During the six months ended July 3, 2021, we recorded an income tax provision of $23.0 on $53.6 of pre-tax income, resulting in an effective tax rate of 42.9%. This compares to an income tax provision for the six months ended June 27, 2020 of $3.0 on $9.6 of pre-tax income, resulting in an effective tax rate of 31.3%. The effective tax rate for the first six months of 2021 was impacted by income tax charges of (i) $4.5 resulting from the disallowance of tax year 2020 interest deductions pursuant to the German Act Implementing the EU Anti-Tax Avoidance Directive, enacted June 30, 2021, (ii) $3.5 resulting from losses occurring in the first six months of 2021 in certain jurisdictions where the tax benefit of those losses is not expected to be realized, and (iii) $1.0 related to transfer pricing adjustments.

26

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

The effective tax rate for the first six months of 2020 was impacted by income tax benefits of (i) $7.2 resulting from adjustments to the deemed repatriation tax and certain additional foreign credits from the recharacterization of a prior outbound transfer of an affiliate to non-U.S. entities and (ii) $1.2 resulting from tax return adjustments for certain of the Company’s subsidiaries, which were partially offset by income tax charges of (i) $6.6 resulting from losses occurring in the first six months of 2020 in certain jurisdictions where the tax benefit of those losses is not expected to be realized and (ii) $1.6 related to the change in valuation allowance related to certain jurisdictions where the benefit of losses are no longer expected to be realized.

We review our income tax positions on a continuous basis and record unrecognized tax benefits for potential uncertain positions when we determine that an uncertain position meets the criteria of the Income Taxes Topic of the Codification. As events change and resolutions occur, adjustments are made to amounts previously provided, such as in the case of audit settlements with taxing authorities.

In connection with the Spin-Off, we and the former Parent entered into a Tax Matters Agreement which, among other matters, addresses the allocation of certain tax adjustments that might arise upon examination of the 2013, 2014 and the pre-Spin-Off portion of the 2015 federal income tax returns of the former Parent. The audit of the federal income tax returns for 2013, 2014 and the pre-Spin-Off portion of 2015 has now been concluded with an immaterial adjustment to the amounts previously reserved.

We have various non-U.S. income tax returns under examination. The most significant of these is the examination in Germany for the 2010 through 2014 tax years. We expect this examination will conclude in 2021. We believe that any uncertain tax positions related to these examinations have been appropriately reflected as unrecognized tax benefits.

As discussed in Note 3, the Sale Agreement with the Buyer of the Company’s Disposal Group includes certain indemnification obligations which we believe are customary for transactions of this nature, including for certain tax obligations, to the extent such obligations relate to fiscal periods prior to the closing date and exceed amounts which are provided for in the balance sheet of the Disposal Group at closing.

An unfavorable resolution of one or more of the above matters could have a material adverse effect on our results of operations or cash flows in the quarter and year in which an adjustment is recorded or the tax is due or paid. As audits and examinations are still in process or we have not yet reached the final stages of the appeals process, the timing of the ultimate resolution and any payments that may be required for the above matters cannot be determined at this time.

(15)     FAIR VALUE

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In the absence of active markets for the identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data, internal information consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy:

•Level 1 — Quoted prices for identical instruments in active markets.

•Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

•Level 3 — Significant inputs to the valuation model are unobservable.

There were no changes during the periods presented to the valuation techniques we use to measure asset and liability fair values on a recurring basis. There were no transfers between the three levels of the fair value hierarchy during the periods presented.

The following section describes the valuation methodologies we use to measure different financial instruments at fair value on a recurring basis.

27

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Derivative Financial Instruments

Our derivative financial assets and liabilities include FX forward contracts and FX embedded derivatives, valued using valuation models based on observable market inputs such as forward rates, interest rates, our own credit risk and the credit risk of our counterparties, which comprise investment-grade financial institutions. Based on these inputs, the derivative assets and liabilities are classified within Level 2 of the valuation hierarchy. We have not made any adjustments to the inputs obtained from the independent sources. Based on our continued ability to enter into forward contracts, we consider the markets for our fair value instruments active. We primarily use the income approach, which uses valuation techniques to convert future amounts to a single present amount.

As of July 3, 2021 and December 31, 2020, the gross fair values of our derivative financial assets and liabilities, in aggregate, were $0.0 and $0.2 (gross assets) and $0.0 and $0.0 (gross liabilities), respectively. As of July 3, 2021, there had been no significant impact to the fair value of our derivative liabilities due to our own credit risk as the related instruments are collateralized under our senior credit facilities. Similarly, there had been no significant impact to the fair value of our derivative assets based on our evaluation of our counterparties’ credit risks.

Equity Security Investment

We hold an investment in an equity security which is reflected at its net asset value in "Other assets" in our condensed consolidated balance sheets as of July 3, 2021 and December 31, 2020 and the change in our investment, based on the equity security's most recently determined net asset value, is reflected in "Other income, net" in our condensed consolidated statements of operations. The net asset value of our investment, utilizing a practical expedient under relevant accounting guidance, is based on our ownership percentage of approximately 19.7% and 18.9% at July 3, 2021 and December 31, 2020, respectively, applied to the equity security’s most recently determined net asset value. During the three and six months ended July 3, 2021, we recorded a gain of $2.1 and $7.5, respectively, to “Other income, net” in our accompanying condensed consolidated statements of operations to reflect an increase in the estimated fair value of the equity security. As of July 3, 2021 and December 31, 2020, the equity security had an estimated fair value of $34.4 and $26.9, respectively. We are restricted from transferring this investment without approval of the manager of the investee.

During the three and six months ended June 27, 2020, we recorded a gain of $5.3 to "Other income, net" in our accompanying condensed consolidated statements of operations to reflect an increase in the estimated fair value of the equity security.

The COVID-19 pandemic has had an adverse impact on global economic conditions. A prolonged adverse impact of the COVID-19 pandemic could result in a decline in the equity security’s estimated fair value and, thus, a resulting charge to earnings in a future period.

Mezzanine Equity

To the extent the noncontrolling interests' put option price is correlated with the estimated fair value of the subsidiary, we use the market method to estimate the fair values of noncontrolling interest put options reported in “Mezzanine equity” using unobservable inputs (Level 3) on a recurring basis. Changes to the noncontrolling interest put option value are reflected as adjustments to “Mezzanine equity” and “Paid-In Capital.” Refer to Note 13 for further discussion.

Goodwill, Indefinite-Lived Intangible and Other Long-Lived Assets

Certain of our non-financial assets are subject to impairment analysis, including long-lived assets, indefinite-lived intangible assets and goodwill. We review the carrying amounts of such assets whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable or at least annually for indefinite-lived intangible assets and goodwill. Any resulting impairment would require that the asset be recorded at its fair value.

During the three and six months ended June 27, 2020, the Company recorded pre-tax losses of $2.0 and $10.5 respectively, to reduce the carrying value of the net assets of its Disposal Group, including relevant foreign currency translation adjustment balances, to the net proceeds expected to be realized upon finalization of the purchase price with the Buyer (see Note 3 for further details regarding the Sale Agreement). The fair value of the Company’s Disposal Group reflected terms of the Sale Agreement with the Buyer as noted above and, as such, was valued using unobservable inputs (Level 3).

28

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

At July 3, 2021, no other significant non-financial assets or liabilities of the Company were required to be measured at fair value on a recurring or non-recurring basis. See Note 3 for further information regarding the losses on Disposal Group recognized during the three and six months ended June 27, 2020, and Note 8 for further information regarding goodwill and indefinite-lived intangible assets, and the Company’s consideration of the effects of the COVID-19 pandemic on its evaluation of the carrying values of such long-lived assets as of July 3, 2021.

Acquisitions

For the POSI-LOCK acquisition, closed during the third quarter of 2020, the purchase price of $10.0 has been allocated to the assets acquired and liabilities assumed based on expert valuations and management’s estimates of their fair values as of the acquisition date. The excess of the purchase price over the aggregate fair values was recorded as "Goodwill" in the accompanying condensed consolidated balance sheets as of July 3, 2021 and December 31, 2020.

For the UTG Mixing Group acquisition, closed during the first quarter of 2021, the purchase price of $38.0 net of cash acquired of $2.9, has been allocated to the assets acquired and liabilities assumed based on expert valuations and management's estimates of their fair values as of the acquisition date. The excess of the purchase price over the aggregate fair values was recorded as "Goodwill" in the accompanying condensed consolidated balance sheet as of July 3, 2021.

For the Philadelphia Mixing acquisition, closed during the second quarter of 2021, the purchase price of $64.6, net of cash acquired of $1.6, has been allocated to the assets acquired and liabilities assumed based on management’s preliminary estimates of their fair values as of the acquisition date. The excess of the purchase price over the aggregate fair values was recorded as "Goodwill" in the accompanying condensed consolidated balance sheet as of July 3, 2021. The estimates of fair values recognized as of July 3, 2021 are preliminary management estimates and are subject to change when such estimates are finalized.

Indebtedness and Other

The estimated fair values of other financial liabilities (excluding finance leases and deferred financing fees) not measured at fair value on a recurring basis as of July 3, 2021 and December 31, 2020 were as follows:

	July 3, 2021				December 31, 2020
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Term loan	$	100.0	$	100.0	$	100.0	$	100.0
5.875% senior notes(1)	300.0		309.8		300.0		313.5
Other indebtedness	15.5		15.5		12.5		12.5

(1)Carrying amount reflected herein excludes related deferred financing fees.

The following methods and assumptions were used in estimating the fair value of these financial instruments:

•The fair values of the senior notes were determined using Level 2 inputs within the fair value hierarchy and were based on quoted market prices for the same or similar instruments or on current rates offered to us for debt with similar maturities, subordination and credit default expectations.

•The fair value of amounts outstanding under our term loan approximated carrying value due primarily to the variable-rate nature and credit spread of this instrument, when compared to other similar instruments.

•The fair values of other indebtedness approximated carrying value due primarily to the short-term nature of these instruments.

The carrying amounts of cash and equivalents, receivables and contract assets reported in our condensed consolidated balance sheets as of July 3, 2021 and December 31, 2020 approximate fair value due to the short-term nature of those instruments.

29

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

(16)     SUBSEQUENT EVENTS

Amendment and Restatement of Senior Credit Facilities

On August 3, 2021 (the “Effective Date”), the Company amended and restated its senior credit facilities (which were previously amended and restated on June 27, 2019) with a syndicate of lenders, which provides for committed senior secured financing in an aggregate amount of $960.5, consisting of the following:

•a domestic revolving credit facility, available for loans and letters of credit, in an aggregate principal amount up to $189.1, with a final maturity of August 3, 2026;

•a global revolving credit facility, available for loans in Euros, Sterling, and other currencies, in an aggregate principal amount up to the equivalent of $283.6, with a final maturity of August 3, 2026;

•a bilateral foreign credit instrument facility, available for performance letters of credit and guarantees in Euros, Sterling, and other currencies, in an aggregate principal amount up to the equivalent of $110.5, with a final maturity of August 3, 2026;

•a new term loan facility in an aggregate principal amount of $100.0, with a final maturity of August 3, 2026; and

•a delayed draw term loan facility in an aggregate principal amount of $277.3, with a final maturity of August 3, 2026.

We also may seek additional commitments, without consent from the existing lenders, to add an incremental term loan facility, increase the commitments in respect of the domestic revolving credit facility, the global revolving credit facility, and/or the bilateral foreign credit instrument facility and/or incur certain other equivalent indebtedness by an aggregate principal amount not to exceed (x) the greater of (i) $275.0 and (ii) an amount equal to 100% of consolidated adjusted EBITDA for the four fiscal quarters ended most recently before such date plus (y) an unlimited amount so long as, immediately after giving effect thereto, our Consolidated Senior Secured Leverage Ratio (as defined in the credit agreement generally as the ratio of consolidated total debt (excluding the face amount of undrawn letters of credit, bank undertakings, or analogous instruments and net of cash and cash equivalents) at the date of determination secured by liens to consolidated adjusted EBITDA for the four fiscal quarters ended most recently before such date) does not exceed 2.75:1.00 plus (z) an amount equal to all voluntary prepayments of the term loan facility and the delayed draw term loan facility and voluntary prepayments accompanied by permanent commitment reductions of the domestic revolving credit facility, the global revolving credit facility, and the bilateral foreign credit instrument facility.

The Company is the borrower under all of the senior credit facilities, and the Company may designate certain of its foreign subsidiaries to be co-borrowers under the global revolving credit facility and the bilateral foreign credit instrument facility.

All borrowings and other extensions of credit under our senior credit facilities are subject to the satisfaction of customary conditions, including absence of defaults and accuracy in material respects of representations and warranties.

The letters of credit under the domestic revolving credit facility are stand-by letters of credit requested by the Company on behalf of itself or any of its subsidiaries or certain joint ventures. The bilateral foreign credit instrument facility is used to issue foreign credit instruments, including bank undertakings to support our foreign operations.

The interest rates applicable to loans under our senior credit facilities are, at our option, equal to either (x) an alternate base rate (the highest of (a) the effective federal funds rate plus 0.5%, (b) the “prime rate” of Bank of America, N.A., and (c) the one-month LIBOR rate plus 1.0%), (y) a reserve-adjusted LIBOR rate for dollars (“Eurodollar”), or (z) certain alternative currency floating rates, plus, in each case, an applicable margin percentage, which varies based on our Consolidated Leverage Ratio (as defined in the credit agreement generally as the ratio of consolidated total debt (excluding the face amount of undrawn letters of credit, bank undertakings or analogous instruments and net of cash and cash equivalents) at the date of determination to consolidated adjusted EBITDA for the four fiscal quarters ended most recently before such date). We may elect interest periods of one, three, or six months (and, if consented to by all relevant lenders, twelve months or less) for Eurodollar rate borrowings and certain alternative currency rate borrowings. The per annum fees charged and the interest rate margins applicable to the loans are as follows:

30

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Consolidated Leverage Ratio	Revolving Credit Facilities Commitment Fee	Financial Letter of Credit Fee	FCI Commitment Fee	FCI Fee and Non-Financial Letter of Credit Fee	Eurodollar / Alternative Currency Loans	ABR Loans
Greater than or equal to 3.00 to 1.0	0.275%	1.750%	0.275%	1.050%	1.750%	0.750%
Less than 3.00 to 1.0 but greater than or equal to 2.00 to 1.0	0.250%	1.500%	0.250%	0.900%	1.500%	0.500%
Less than 2.00 to 1.0 but greater than or equal to 1.50 to 1.0	0.225%	1.375%	0.225%	0.825%	1.375%	0.375%
Less than 1.50 to 1.0	0.200%	1.250%	0.200%	0.750%	1.250%	0.250%

The fees for bilateral foreign credit commitments are as specified above for foreign credit instrument commitments unless otherwise agreed with the bilateral foreign issuing lender. We also pay fronting fees on the outstanding amounts of financial letters of credit at the rate of 0.125% per annum and non-financial letters of credit at the rate of 0.250% per annum.

Our senior credit facilities require mandatory prepayments in amounts equal to the net proceeds from the sale or other disposition of, including from any casualty to, or governmental taking of, property in excess of specified values (other than in the ordinary course of business and subject to other exceptions) by the Company or its subsidiaries. Mandatory prepayments will be applied to repay, first, amounts outstanding under any term loans (including delayed draw term loans) and, then, amounts outstanding under the global revolving credit facility and the domestic revolving credit facility (without reducing the commitments thereunder). No prepayment is required generally to the extent the net proceeds are reinvested (or committed to be reinvested) in permitted acquisitions, permitted investments or assets to be used in our business within 360 days (and if committed to be reinvested, actually reinvested within 180 days after the end of such 360-day period) of the receipt of such proceeds.

We may voluntarily prepay loans under our senior credit facilities, in whole or in part, without premium or penalty. Any voluntary prepayment of loans will be subject to reimbursement of the lenders’ breakage costs in the case of a prepayment of Eurodollar rate or alternative currency term rate borrowings other than on the last day of the relevant interest period.

Indebtedness under our senior credit facilities is guaranteed by:

•each existing and subsequently acquired or organized domestic material subsidiary of the Company (with certain exceptions); and

•solely with respect to the obligations of our foreign borrower subsidiaries under the global revolving credit facility and the bilateral foreign credit instrument facility, the Company.

Indebtedness under our senior credit facilities is secured by (i) a first priority pledge and security interest in 100% of the capital stock of our domestic subsidiaries (with certain exceptions) held by the Company or the domestic subsidiary guarantors and 65% of the capital stock of our material first-tier foreign subsidiaries (with certain exceptions), (ii) first priority security interests and other liens on substantially all of the personal property of the Company and its domestic subsidiary guarantors (with certain exceptions), and (iii) a lien on our corporate headquarters. If the Company’s corporate credit rating is “Baa3” or better by Moody’s or “BBB-” or better by S&P and no defaults exist or would result therefrom, then all collateral security will be released and the indebtedness under our senior credit facilities will be unsecured.

Our senior credit facilities require that the Company maintains:

•a Consolidated Interest Coverage Ratio (as defined in the credit agreement generally as the ratio of consolidated adjusted EBITDA for the four fiscal quarters ended on such date to consolidated cash interest expense for such period) as of the last day of any fiscal quarter of at least 3.00 to 1.00; and

•a Consolidated Leverage Ratio as of the last day of any fiscal quarter of not more than 4.00 to 1.00.

31

SPX FLOW, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(Unaudited; in millions, except per share data)

Our senior credit facilities also contain covenants that, among other things, restrict our ability to incur additional indebtedness, grant liens, make investments, loans, guarantees, or advances, make restricted junior payments, including dividends, redemptions of capital stock, and voluntary prepayments or repurchase of certain other indebtedness, engage in mergers, acquisitions or sales of assets, or engage in certain transactions with affiliates, and otherwise restrict certain corporate activities. Our senior credit facilities contain customary representations, warranties, affirmative covenants and events of default.

We are permitted under our senior credit facilities to repurchase our capital stock and pay cash dividends in an unlimited amount if our Consolidated Leverage Ratio is (after giving pro forma effect to such payments) less than 2.50 to 1.00. If our Consolidated Leverage Ratio is (after giving pro forma effect to such payments) greater than or equal to 2.50 to 1.00, the aggregate amount of such repurchases and dividend declarations cannot exceed (A) $100.0 in any fiscal year plus (B) an additional amount for all such repurchases and dividend declarations made after the Effective Date equal to the sum of (i) $300.0 plus (ii) a positive amount equal to 50% of cumulative Consolidated Net Income (as defined in the credit agreement generally as consolidated net income subject to certain adjustments solely for the purposes of determining this basket) during the period from the Effective Date to the end of the most recent fiscal quarter preceding the date of such repurchase or dividend declaration for which financial statements have been (or were required to be) delivered (or, in case such Consolidated Net Income is a deficit, minus 100% of such deficit) plus (iii) certain other amounts.

The proceeds of the initial borrowing were used in part to repay the term loan outstanding under our senior credit facility which was in effect as of July 3, 2021 (the "Former Senior Credit Facility"). In connection with entering into the amended and restated senior credit facility in August 2021, we expect to record a pre-tax charge as a "Loss on Early Extinguishment of Debt" during our third quarter of 2021, which we expect to include primarily the write-off of certain unamortized deferred financing fees resulting from the extinguishment of the term loan and other facilities of the Former Senior Credit Facility.

Redemption of 2026 Notes

On August 3, 2021, the Company issued an irrevocable notice of redemption (the “Notice”) with respect to its 5.875% Senior Notes due 2026 (the “2026 Notes”). Pursuant to the Notice, the Company gave holders of the 2026 Notes notice that it will redeem all of the outstanding 2026 Notes on September 2, 2021 (the “Redemption Date”). The 2026 Notes, which have an outstanding principal balance of $300.0, will be redeemed in full pursuant to the redemption provisions of the indenture governing the 2026 Notes for a redemption price equal to 102.938% of the principal amount thereof, plus accrued and unpaid interest to, but not including, the Redemption Date. The Company plans to fund the redemption with the proceeds of the delayed draw term loan under the senior credit facilities and other available cash.

In connection with the redemption of the 2026 Notes, we expect to record a pre-tax charge as a "Loss on Early Extinguishment of Debt" during our third quarter of 2021, which we expect to include primarily premiums incurred to redeem the 2026 Notes and, to a lesser extent, the write-off of unamortized deferred financing fees.

Sale of a Product Line

On July 30, 2021, we completed the sale of the primary assets of a product line to a third-party buyer for cash proceeds of $8.0. Revenues associated with this product line were less than $4.0 in 2020, and the results of this product line are included in our Precision Solutions reportable segment. In connection with the sale, we expect to record a pre-tax gain as a component of “Other income (expense), net” during our third quarter of 2021.

32

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (in millions, unless otherwise noted)

FORWARD-LOOKING STATEMENTS

Some of the statements in this document and any documents incorporated by reference, including any statements as to operational and financial projections, constitute “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our businesses’ or our industries’ actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements. Such statements may address our plans, our strategies, our prospects, or changes and trends in our business and the markets in which we operate under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”) or in other sections of this document. In some cases, you can identify forward-looking statements by terminology such as “may,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential” or “continue” or the negative of those terms or similar expressions. These statements are only predictions. Actual events or results may differ materially because of market conditions in our industries or other factors, and forward-looking statements should not be relied upon as a prediction of actual results. Among other factors that may affect future performance are: the impact of the global outbreak of COVID-19 and governmental and other actions taken in response; cyclical changes and specific industry events in the company’s markets; changes in anticipated capital investment and maintenance expenditures by customers; availability, limitations or cost increases of raw materials, component products and/or commodities that cannot be recovered in product pricing; overruns, the incurrence of delays, penalties or liquidated damages with respect to long-term fixed-price contracts; international economic, political, legal, accounting and business developments adversely affecting the company’s ability to do business in emerging markets; ability to identify acceptable strategic acquisition targets; uncertainties surrounding timing, successful completion or integration of acquisitions and similar transactions; inadequate performance by third-party suppliers and subcontractors for outsourced products; defects or errors in current or planned products; potential labor disputes, extreme weather conditions and natural and other disasters; compliance costs associated with environmental laws and regulations; threats associated with and efforts to combat terrorism and cyber-security risks; global competitive market conditions, including global reactions to U.S. trade policies, and resulting effects on sales and pricing; and global economic factors, including currency exchange rates, difficulties entering new markets and general economic conditions such as inflation, deflation, interest rates and credit availability. In addition, management’s estimates of future operating results are based on our current complement of continuing operations, which is subject to change as management selects strategic markets.

All the forward-looking statements in this document are qualified in their entirety by reference to the factors discussed herein and under the heading “Risk Factors” in our 2020 Annual Report on Form 10-K and in any other documents subsequently filed by us under the Exchange Act that describe risks and factors that could cause results to differ materially from those projected in these forward-looking statements. We caution you that these risk factors may not be exhaustive. We operate in a continually changing business environment and frequently enter into new businesses and product lines. We cannot predict these new risk factors, and we cannot assess the impact, if any, of these new risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those projected in any forward-looking statements. Accordingly, you should not rely on forward-looking statements as a prediction of actual results. We undertake no obligation to update or publicly revise any forward-looking statements to reflect events or circumstances that arise after the date of this document.

33

EXECUTIVE OVERVIEW

Impact of the COVID-19 Pandemic

As further discussed below, the COVID-19 pandemic had an adverse impact on our condensed consolidated financial results for the three and six months ended July 3, 2021. These adverse impacts are expected to continue, to a lesser degree, in future quarters of 2021, and possibly longer, but we are unable to determine the extent, duration, or nature at this time. Although certain of our product lines (e.g., shorter-cycle product lines within our Precision Solutions reportable segment) have been impacted more than others in our portfolio, we believe that our diverse set of products, along with our strong balance sheet position and available liquidity, position us well to mitigate further potential adverse impacts of the COVID-19 pandemic. For example, because we serve customers which produce food, beverages, personal care items, cleaning products, pharmaceuticals, and specialty chemicals, and serve critical infrastructure and industrial enablement functions, a majority, but not all, of our products, services and operations have been classified as “essential” under various governmental orders restricting business activities implemented in response to the COVID-19 pandemic. While we have temporarily closed certain of our offices and engineering, service and manufacturing centers during 2020 and 2021, and may be required to close additional facilities in the future in response to governmental orders, other COVID-19 pandemic safety-related concerns or in response to market conditions affected by COVID-19, our manufacturing facilities have not experienced significant interruptions in operations to date.

In terms of liquidity, as of July 3, 2021, we had over $320 of cash and equivalents on hand and, as discussed in Note 10 to the accompanying condensed consolidated financial statements, approximately $490 of borrowing capacity under our revolving credit facilities and no debt repayments due under primary debt obligations until June 2022. During the past year, we have taken actions to manage costs and cash flows, including reducing discretionary spending, and will continue to assess the actual and expected impacts of the COVID-19 pandemic and any requirements for further actions.

See Note 16 to our accompanying condensed consolidated financial statements for information regarding certain subsequent events impacting the Company's indebtedness, including (i) our notification to bondholders of our irrevocable intent to redeem the full principal amount of our senior notes during the third quarter of 2021, and (ii) an amendment to our senior credit facilities executed during the third quarter of 2021.

Discontinued Operations

    On May 2, 2019, the Company announced that its Board of Directors had initiated a process to divest a substantial portion of the Company’s former Power and Energy reportable segment, excluding the Bran+Luebbe product line (collectively, the “Disposal Group”). In connection with this announcement and the continued development of the divestiture process thereafter, we reported the Disposal Group as “held-for-sale”, and as discontinued operations, initially as of the end of our second quarter of 2019.

In November 2019, we entered into a Purchase and Sale Agreement (the “Sale Agreement”) with an affiliate of Apollo Global Management, LLC (the “Buyer”), pursuant to which the Company agreed, indirectly through certain of its subsidiaries, to sell the businesses reflected as discontinued operations in the accompanying condensed consolidated financial statements to the Buyer for a gross purchase price of $475.0 (the “Transaction”). The gross purchase price of $475.0 was subject to (i) reductions based upon the level of certain deductions of the Disposal Group at the closing date, and (ii) certain adjustments based upon the level of net working capital, cash and debt of the Disposal Group at the closing date. The deductions included, for example, components of the "Contract Liabilities" and certain other current and long-term liabilities of the Disposal Group, as well as deductions for budgeted but un-incurred capital expenditures and other business infrastructure costs measured over periods defined in the Sale Agreement, but in all cases which expired at the closing date. On March 30, 2020, we completed the sale of substantially all Disposal Group businesses and received proceeds from the Buyer of $406.2, based on an estimate of certain adjustments to the gross purchase price as of the closing date and as discussed further above and, to a lesser extent, certain fees.

    Unless otherwise indicated, amounts provided in MD&A below pertain to continuing operations only.

34

Our Business

SPX FLOW operates in two reportable segments: the Nutrition and Health segment and the Precision Solutions segment. During the first quarter of 2021, the Company renamed its former "Food and Beverage" segment to the "Nutrition and Health" segment. During July 2021, the Company renamed its former "Industrial" segment to the "Precision Solutions" segment. Accordingly, all current and comparative period financial information for these segments has been presented as the Nutrition and Health segment and the Precision Solutions segment in this MD&A. Other than the changes in name, there were no changes to the segments and there has been no change to prior period financial information of the segments.

Based in Charlotte, North Carolina, SPX FLOW innovates with customers to help feed and enhance the world by designing, delivering and servicing high-value process solutions at the heart of growing and sustaining our diverse communities. The product offering of the Company's continuing operations is concentrated in process technologies that perform mixing, blending, fluid handling, separation, thermal heat transfer and other activities that are integral to processes performed across a wide variety of nutrition, health and precision solution markets. SPX FLOW had approximately $1.4 billion in 2020 annual revenues, with approximately 36%, 37% and 27% from sales into the Americas, EMEA and Asia Pacific regions, respectively, and has continuing operations in more than 30 countries and sales in more than 140 countries.

Our product portfolio of pumps, valves, mixers, filters, air dryers, hydraulic tools, homogenizers, separators and heat exchangers, along with the related aftermarket parts and services, supports global industries, including nutrition and health, chemical processing, compressed air and mining. From an end-market perspective, in 2020, approximately 47% of our revenues were from sales into the nutrition and health end markets and approximately 53% were from sales into the precision solutions end markets. Our core strengths include expertise in rotating, actuating and hydraulic equipment, a highly skilled workforce, global capabilities, product breadth, and a deep application knowledge that enables us to optimize configuration and create custom-engineered solutions for diverse processes.

The following summary describes the products and services offered by our reportable segments:

Nutrition and Health: The Nutrition and Health reportable segment operates in a regulated, global industry with customers who demand highly engineered process solutions. Key demand drivers include dairy consumption, emerging market capacity expansion, sustainability and productivity initiatives, customer product innovation and food safety. Key products for the segment include homogenizers, pumps, valves, separators and heat exchangers. We also design and assemble process systems that integrate many of these products for our customers. Key brands include APV, Gerstenberg Schroeder, Seital and Waukesha Cherry-Burrell. The segment's primary competitors are Alfa Laval AB, Fristam Pumps, GEA Group AG, Krones AG, Südmo, Tetra Pak International S.A. and various regional companies.

Precision Solutions: The Precision Solutions reportable segment primarily serves customers in the chemical, air treatment, mining, pharmaceutical, marine, infrastructure construction, general industrial and water treatment industries. Key demand drivers of this segment are tied to macroeconomic conditions and growth in the respective end markets we serve. Key products for the segment are air dryers, filtration equipment, mixers, pumps, hydraulic technologies and heat exchangers. Key brands include Airpel, APV, Bolting Systems, Bran+Luebbe, Deltech, Hankison, Jamix, Jemaco, Johnson Pump, LIGHTNIN, Philadelphia Mixing Solutions, POSI LOCK, Power Team, Stelzer, Stone and Uutechnic. The segment's primary competitors are Alfa Laval AB, Chemineer Inc., EKATO, Enerpac, IDEX Viking Pump, KSB AG, Lewa, Milton Roy, Parker Domnick Hunter, Prominent and various regional companies.

Summary of Operating Results

Non-GAAP Measures - Throughout the following segment discussion, we use organic revenue growth (decline) to facilitate explanation of the operating performance of our segments. Organic revenue growth (decline) is a non-GAAP financial measure, and is not a substitute for net revenue growth (decline). Refer to the explanation of this measure and purpose of use by management under “Results of Continuing Operations-Non-GAAP Measures.”

The financial information discussed below and included in this Quarterly Report on Form 10-Q may not necessarily reflect what our financial condition, results of operations and cash flows may be in the future.

The following summary is intended to provide certain highlights of the discussion and analysis that follows (all comparisons are to the related period in the prior year):

35

Revenues — For the three and six months ended July 3, 2021, revenues increased $73.5 (23.9%) and $147.8 (24.7%), respectively. The increases in revenue were driven primarily by (i) increases in organic revenue and, to a lesser extent, (ii) the weakening of the U.S. dollar against various foreign currencies during the periods and (iii) revenues associated with businesses acquired in the third quarter of 2020 and first and second quarters of 2021. The increases in organic revenue were due primarily to higher volumes of revenue from (i) Nutrition and Health segment systems, components and aftermarket products, and (ii) broad-based strengthening across most short-cycle Precision Solutions segment product lines, attributable primarily to increased demand due to reduced adverse effects of the COVID-19 pandemic.

Income before Income Taxes — Income before income taxes increased $15.7 (148.1%) and $44.0 (458.3%) in the three and six months ended July 3, 2021, respectively. The increase in pre-tax income for the three months ended July 3, 2021, compared to the respective 2020 period, included primarily the effects of an increase in segment income and, to a lesser extent, reductions in interest expense and corporate expense, partially offset by a lower gain recognized on an investment in an equity security.

The increase in pre-tax income for the six months ended July 3, 2021, compared to the respective 2020 period, included primarily the effects of an increase in segment income and, to a lesser extent, reductions in interest expense and corporate expense, and a larger gain recognized on an investment in an equity security, partially offset by the effects of an increase in restructuring and other related charges.

Cash Flows from (used in) Operations — For the six months ended July 3, 2021, cash flows from (used in) operations increased to $33.9 from $(7.5) in the comparable prior year period, primarily as a result of increased cash flows from higher segment income and the effects of improvements in working capital management realized during the 2021 period.

RESULTS OF OPERATIONS

The unaudited information included in this Quarterly Report on Form 10-Q should be read in conjunction with our annual consolidated financial statements included in our 2020 Annual Report on Form 10-K. Interim results are not necessarily indicative of results for a full year. We establish actual interim closing dates using a fiscal calendar, which requires our businesses to close their books on the Saturday closest to the end of the first calendar quarter, with the second and third quarters being 91 days in length. Our fourth quarter ends on December 31. The interim closing dates for the first, second and third quarters of 2021 are April 3, July 3, and October 2, compared to the respective March 28, June 27, and September 26, 2020 dates. We had five more days in the first quarter of 2021 and will have six fewer days in the fourth quarter of 2021 than in the respective 2020 periods. It is not practicable to estimate the impact of the differential in number of days on our changes in revenues for the six-month period ended July 3, 2021 compared to the prior-year period.

Cyclicality of End Markets, Seasonality and Competition - The financial results of many of our businesses closely follow changes in the industries and end markets they serve.

In our Nutrition and Health reportable segment, system revenues are highly correlated to timing on capital projects, which may cause significant fluctuations in our financial performance from period to period. Fluctuations in dairy commodity prices and production of dairy related products, particularly those aimed at serving the China market, can influence the timing of capital spending by many end customers in our Nutrition and Health reportable segment.

Although our businesses operate in highly competitive markets, our competitive position cannot be determined accurately in the aggregate or by segment since our competitors do not offer all the same product lines or serve all the same markets. In addition, specific reliable comparative figures are not available for many of our competitors. In most product groups, competition comes from numerous concerns, both large and small. The principal methods of competition are service, product performance, technical innovation and price. These methods vary with the type of product sold. We believe we compete effectively on the basis of each of these factors. See “Executive Overview - Our Business” for a discussion of our competitors.

36

Non-GAAP Measures - Organic revenue growth (decline) presented herein is defined as revenue growth (decline) excluding the effects of foreign currency fluctuations and business acquisitions which occurred in the third quarter of 2020 and first and second quarters of 2021. We believe this metric is a useful financial measure for investors in evaluating our operating performance for the periods presented as, when read in conjunction with our revenues, it presents a tool to evaluate our ongoing operations and provides investors with a metric they can use to evaluate our management of assets held from period to period. In addition, organic revenue growth (decline) is one of the factors we use in internal evaluations of the overall performance of our business. This metric, however, is not a measure of financial performance under accounting principles generally accepted in the United States (“GAAP”), should not be considered a substitute for net revenue growth (decline) as determined in accordance with GAAP and may not be comparable to similarly titled measures reported by other companies.

The following table provides selected financial information for the three and six months ended July 3, 2021 and June 27, 2020, respectively, including the reconciliation of organic revenue growth to net revenue growth:

	Three months ended							Six months ended
	July 3, 2021			June 27, 2020			% Change	July 3, 2021			June 27, 2020			% Change
Revenues	$	381.6		$	308.1		23.9	$	745.4		$	597.6		24.7
Gross profit	131.7			113.5			16.0	260.2			214.6			21.2
% of revenues	34.5		%	36.8		%		34.9		%	35.9		%
Selling, general and administrative	93.8			90.8			3.3	184.2			176.0			4.7
% of revenues	24.6		%	29.5		%		24.7		%	29.5		%
Intangible amortization	4.7			2.9			62.1	7.7			5.7			35.1
Asset impairment charges	—			0.8			(100.0)	—			2.7			(100.0)
Restructuring and other related charges	4.3			4.8			(10.4)	13.5			7.4			82.4
Other income, net	2.3			5.8			(60.3)	8.6			4.3			100.0
Interest expense, net	(4.9)			(9.4)			(47.9)	(9.8)			(17.5)			(44.0)
Income from continuing operations before income taxes	26.3			10.6			148.1	53.6			9.6			*
Income tax provision	(14.7)			(3.9)			*	(23.0)			(3.0)			*
Income from continuing operations	11.6			6.7			73.1	30.6			6.6			*
Loss from discontinued operations, net of tax	(0.6)			(31.6)			(98.1)	(0.9)			(36.7)			(97.5)
Net income (loss)	11.0			(24.9)			*	29.7			(30.1)			*
Less: Net income attributable to noncontrolling interests	0.2			0.2			—	0.3			0.3			—
Net income (loss) attributable to SPX FLOW, Inc.	10.8			(25.1)			*	29.4			(30.4)			*
Components of consolidated revenue growth:
Organic increase							14.1							16.2
Foreign currency							5.5							5.3
Business combinations							4.3							3.2
Net revenue increase							23.9							24.7
* Not meaningful for comparison purposes

Revenues - For the three and six months ended July 3, 2021, the increases in revenues, compared to the respective 2020 periods, were driven primarily by (i) increases in organic revenue and, to a lesser extent, (ii) the weakening of the U.S. dollar against various foreign currencies during the periods and (iii) revenues associated with businesses acquired in the third quarter of 2020 and first and second quarters of 2021. The increases in organic revenue were driven primarily by higher volumes of revenue from (i) Nutrition and Health segment systems, components and aftermarket products, and (ii) broad-based strengthening across most short-cycle Precision Solutions segment product lines, attributable primarily to increased demand due to reduced adverse effects of the COVID-19 pandemic.

See “Results of Reportable Segments” for additional details.

37

Gross Profit - The increases in gross profit for the three and six months ended July 3, 2021, compared to the respective 2020 periods, were driven primarily by favorable price realization along with the increased revenues as noted above. The decreases in gross margins for the three and six months ended July 3, 2021, compared to the respective 2020 periods, were primarily attributable to cost increases in certain operational areas such as freight and certain types of labor costs, the effects of which were partially mitigated by the favorable impact on operating leverage of the higher volumes of revenues, as well as an improved mix of higher-quality revenue in our Nutrition and Health reportable segment.

See “Results of Reportable Segments” for additional details.

Selling, General and Administrative (“SG&A”) Expense - For the three and six months ended July 3, 2021, the increases in SG&A expense, compared to the respective 2020 periods, were due primarily to the weakening of the U.S. dollar against various foreign currencies during the periods and, to a lesser extent, increases in variable incentive compensation. These increases in costs were partially offset by savings from (i) reductions in discretionary spending and (ii) reductions in force associated with restructuring actions taken in 2020 as well as our global cost productivity program, initiated during the first quarter of 2021.

Intangible Amortization - The increases in intangible amortization for the three and six months ended July 3, 2021, compared to the respective 2020 periods, were primarily due to amortization of intangible assets acquired in the POSI LOCK, UTG Mixing Group and Philadelphia Mixing acquisitions closed in the third quarter of 2020 and first and second quarters of 2021, respectively.

Asset Impairment Charges - Charges for the three and six months ended June 27, 2020 resulted from management's decisions to (i) consolidate and relocate the operations of a U.S. manufacturing facility within the Precision Solutions reportable segment to existing facilities in the U.S. as well as in our EMEA and Asia Pacific regions, and (ii) discontinue a product line within the Precision Solutions reportable segment.

Restructuring and Other Related Charges - Charges for the three and six months ended July 3, 2021 related to a global cost productivity program initiated during the first quarter of 2021. Such charges related primarily to severance and other costs associated with commercial, engineering and certain operational employees across both segments and across each region in which our segments operate, as well as certain functional support employees across most of our corporate functions.

See Note 6 to our condensed consolidated financial statements for further details of actions taken during the three and six months ended July 3, 2021 and June 27, 2020.

Other Income, net - Other income, net, for the three months ended July 3, 2021 was composed primarily of investment-related gains of $2.1, income from a transition services agreement (the "TSA") entered into in connection with the sale of our former Power and Energy segment of $0.5, and net gains on asset sales and other of $0.2, partially offset by foreign currency (“FX”) losses of $0.5. The investment-related gains related to an increase in the net asset value of our investment in an equity security (see Note 15 to the condensed consolidated financial statements for additional details). See Note 3 for additional details regarding the TSA.

Other income, net, for the three months ended June 27, 2020 was composed primarily of investment-related gains of $5.3 and income from the TSA of $1.5, partially offset by FX losses of $1.0.

Other income, net, for the six months ended July 3, 2021 was composed primarily of investment-related gains of $7.5, income from the TSA of $1.5 and net gains on assets sales and other of $0.3, offset by FX losses of $0.6 and non-service related pension and postretirement costs of $0.2.

Other income, net, for the six months ended June 27, 2020 was composed of investment-related gains of $5.3 and income from the TSA of $1.5, partially offset by FX losses of $1.8, net losses on asset sales and other of $0.4, and non-service-related pension and postretirement costs of $0.3.

Interest Expense, net - Interest expense, net, for the three and six months ended July 3, 2021 and June 27, 2020, was composed primarily of interest expense related to our senior notes and senior credit facilities and, to a lesser extent, finance lease obligations and miscellaneous lines of credit, partially offset by interest income on cash and cash equivalents.

    Interest expense, net, included interest expense of $5.9 and $10.5, and interest income of $1.0 and $1.1, respectively, during the three months ended July 3, 2021 and June 27, 2020. Interest expense, net, included interest expense of $11.8 and $19.6, and interest income of $2.0 and $2.1, respectively, during the six months ended July 3, 2021 and June 27, 2020. The decreases in interest expense in 2021, compared to 2020, were due primarily to the early redemption of our 5.625% senior notes in August 2020.

38

    See Note 10 to our condensed consolidated financial statements for additional details on our third-party debt and Note 3 for additional details regarding our allocation of certain interest expense to discontinued operations.

Income Tax Provision - During the three months ended July 3, 2021, we recorded an income tax provision of $14.7 on $26.3 of pre-tax income, resulting in an effective tax rate of 55.9%. This compares to an income tax provision for the three months ended June 27, 2020 of $3.9 on $10.6 of pre-tax income, resulting in an effective tax rate of 36.8%. The effective tax rate for the second quarter of 2021 was impacted by income tax charges of (i) $4.5 resulting from the disallowance of tax year 2020 interest deductions pursuant to the German Act Implementing the EU Anti-Tax Avoidance Directive, enacted June 30, 2021, (ii) $1.8 resulting from losses occurring in the quarter in certain jurisdictions where the benefit of those losses is not expected to be realized, and (iii) $1.0 related to transfer pricing adjustments.

The effective tax rate for the second quarter of 2020 was impacted by income tax charges of (i) $6.0 resulting from losses occurring in the quarter in certain jurisdictions where the tax benefit of those losses is not expected to be realized and (ii) $1.6 related to the change in valuation allowance related to certain jurisdictions where the benefit of losses are no longer expected to be realized, which were partially offset by an income tax benefit of $7.2 resulting from adjustments to the deemed repatriation tax and certain additional foreign credits from the recharacterization of a prior outbound transfer of an affiliate to non-U.S. entities.

During the six months ended July 3, 2021, we recorded an income tax provision of $23.0 on $53.6 of pre-tax income, resulting in an effective tax rate of 42.9%. This compares to an income tax provision for the six months ended June 27, 2020 of $3.0 on $9.6 of pre-tax income, resulting in an effective tax rate of 31.3%. The effective tax rate for the first six months of 2021 was impacted by income tax charges of (i) $4.5 resulting from the disallowance of tax year 2020 interest deductions pursuant to the German Act Implementing the EU Anti-Tax Avoidance Directive, enacted June 30, 2021, (ii) $3.5 resulting from losses occurring in the first six months of 2021 in certain jurisdictions where the tax benefit of those losses is not expected to be realized, and (iii) $1.0 related to transfer pricing adjustments.

The effective tax rate for the first six months of 2020 was impacted by income tax benefits of (i) $7.2 resulting from adjustments to the deemed repatriation tax and certain additional foreign credits from the recharacterization of a prior outbound transfer of an affiliate to non-U.S. entities and (ii) $1.2 resulting from tax return adjustments for certain of the Company’s subsidiaries, which were partially offset by income tax charges of (i) $6.6 resulting from losses occurring in the first six months of 2020 in certain jurisdictions where the tax benefit of those losses is not expected to be realized and (ii) $1.6 related to the change in valuation allowance related to certain jurisdictions where the benefit of losses are no longer expected to be realized.

Our future effective tax rate may vary, particularly during the first quarter of each year, based on tax charges or benefits that could result from potential future vestings of restricted stock shares and restricted stock units.

Loss from Discontinued Operations, Net of Tax - For the three and six months ended July 3, 2021, the loss from discontinued operations, net of tax, of $0.6 and $0.9, respectively, related to certain trailing costs incurred related to the sale of the Disposal Group.

For the three and six months ended June 27, 2020, the loss from discontinued operations, net of tax, of $31.6 and $36.7, respectively, were primarily composed of an income tax provision of $29.0 and $28.1, respectively, on $2.6 and $8.6, respectively, of pre-tax loss from discontinued operations. Among other items, the income tax provision for the three months ended June 27, 2020 was impacted by income tax charges of (i) $32.1 composed of U.S. tax expense on the tax gain on sale of Disposal Group entities sold by the U.S. parent and (ii) $1.6 in reduction of the benefit to be realized through the disposition of held-for-sale assets, which were partially offset by an income tax benefit of $4.9 related to a loss for global intangible low-taxed income purposes on the sale of certain non-U.S. entities. The significant non-U.S. sales of Disposal Group entities were in locations where local law did not require any gain to be taxed or permit any loss to result in a future benefit. In addition to these, the income tax provision for the six months ended June 27, 2020 also included the effect from the first quarter of 2020 that the majority of the pre-tax loss on Disposal Group was not deductible in the various jurisdictions where the sale of the Disposal Group was to be recognized. As such, only $1.2 of tax benefit was recognized on the $8.6 pre-tax loss on Disposal Group. The losses from discontinued operations, net, for the three and six months ended June 27, 2020, also reflected pre-tax losses recorded of $2.0 and $10.5, respectively, to reduce the carrying value of the Disposal Group to our estimate of the net proceeds expected to be realized upon finalization of the purchase price with the Buyer. See Note 3 to the condensed consolidated financial statements for further discussion regarding such losses on Disposal Group.

39

RESULTS OF REPORTABLE SEGMENTS

The following information should be read in conjunction with our condensed consolidated financial statements and related notes.

Nutrition and Health

	As of and for the three months ended							As of and for the six months ended
	July 3, 2021			June 27, 2020			% Change	July 3, 2021			June 27, 2020			% Change
Backlog	$	267.1		$	263.5		1.4	$	267.1		$	263.5		1.4
Orders	171.0			150.9			13.3	343.8			276.1			24.5
Revenues	168.3			144.7			16.3	339.9			282.5			20.3
Income	26.4			19.1			38.2	55.0			38.5			42.9
% of revenues	15.7		%	13.2		%		16.2		%	13.6		%
Components of revenue growth:
Organic increase							10.5							14.7
Foreign currency							5.8							5.6
Net revenue growth							16.3							20.3

Revenues - For the three and six months ended July 3, 2021, the increases in revenues, compared to the respective 2020 periods, were driven primarily by increases in organic revenue and, to a lesser extent, a weakening of the U.S. dollar during the periods against various foreign currencies. The increases in organic revenue were due to higher volumes of systems, components and aftermarket revenues, partially attributable to reduced adverse effects of the COVID-19 pandemic.

Income - For the three and six months ended July 3, 2021, income and margin increased, compared to the respective 2020 periods. The increases in income and margin were driven primarily by the favorable impact on operating leverage of higher volumes of revenues as discussed above, as well as an improved mix of higher-quality revenue.

Backlog - The segment had backlog of $267.1 and $263.5 as of July 3, 2021 and June 27, 2020, respectively. Of the $3.6 year-over-year increase in backlog, $16.4 was attributable to the favorable impact of fluctuations in foreign currencies relative to the U.S. dollar, offset by $12.8 in organic decline across systems, components and aftermarket product lines, partially due to the increased revenue levels realized in the six months ended July 3, 2021 which resulted partially from the reduced adverse effects of the COVID-19 pandemic.

Precision Solutions

	As of and for the three months ended							As of and for the six months ended
	July 3, 2021			June 27, 2020			% Change	July 3, 2021			June 27, 2020			% Change
Backlog	$	341.4		$	282.8		20.7	$	341.4		$	282.8		20.7
Orders	234.0			169.5			38.1	432.7			361.3			19.8
Revenues	213.3			163.4			30.5	405.5			315.1			28.7
Income	23.6			19.9			18.6	45.0			29.3			53.6
% of revenues	11.1		%	12.2		%		11.1		%	9.3		%
Components of revenue growth:
Organic increase							17.3							17.6
Business combinations							8.1							6.1
Foreign currency							5.1							5.0
Net revenue growth							30.5							28.7

40

Revenues - For the three and six months ended July 3, 2021, the increases in revenues, compared to the respective 2020 periods, were driven primarily by (i) increases in organic revenue and, to a lesser extent, (ii) revenues associated with businesses acquired in the third quarter of 2020 and first and second quarters of 2021, and (iii) a weakening of the U.S. dollar during the periods against various foreign currencies. The increases in organic revenue were driven primarily by increased shipments across substantially all of our short-cycle Precision Solutions segment product lines and end markets, primarily associated with reduced adverse effects of the COVID-19 pandemic.

Income - For the three and six months ended July 3, 2021, income increased, compared to the respective 2020 periods. The increases in income were driven primarily by the favorable impact on operating results of higher volumes of revenues as discussed above. Operationally, favorable impacts of price realization, higher volumes and SG&A cost reductions were partially offset by elevated freight costs to support key customers and lower labor productivity due to a large number of new employees. The decrease in margin for the three months ended July 3, 2021, compared to the respective 2020 period, primarily resulted from increased intangible amortization expense and the impact of fair value adjustments to inventory directly attributable to the Company's acquisition strategy and, to a lesser extent, a higher mix of OE revenue.

For the six months ended July 3, 2021, margin increased, compared to the respective 2020 period, primarily driven by improved leverage on higher volumes of revenues, partially offset by the effects of cost increases in certain operational areas such as freight and certain types of labor costs as noted above.

Backlog - The segment had backlog of $341.4 and $282.8 as of July 3, 2021 and June 27, 2020, respectively. The $58.6 year-over-year increase in backlog was attributable to (i) a $37.7 increase in backlog associated with acquired businesses, (ii) a $16.8 favorable impact of fluctuations in foreign currencies relative to the U.S. Dollar, and (iii) a $4.1 increase in backlog related to legacy operations.

CORPORATE EXPENSE AND PENSION AND POSTRETIREMENT SERVICE COSTS

	Three months ended							Six months ended
	July 3, 2021			June 27, 2020			% Change	July 3, 2021			June 27, 2020			% Change
Total consolidated revenues	$	381.6		$	308.1		23.9	$	745.4		$	597.6		24.7
Corporate expense	16.6			19.0			(12.6)	31.3			34.5			(9.3)
% of revenues	4.4		%	6.2		%		4.2		%	5.8		%
Pension and postretirement service costs	0.2			0.2			—	0.4			0.4			—

Corporate Expense - Corporate expense generally relates to the cost of our Charlotte, North Carolina corporate headquarters and our Asia Pacific center in Shanghai, China. Corporate expense also reflects stock-based compensation costs associated with corporate employees.

The decrease in corporate expense for the three and six months ended July 3, 2021, compared to the respective 2020 period, was due primarily to actions taken to manage costs on a year-over-year basis, including (i) reductions in force of certain functional support employees across most of our corporate functions and (ii) reductions in discretionary spending, related to our global cost productivity program announced during the first quarter of 2021, as well as in response to the ongoing effects of the COVID-19 pandemic.

See Note 12 to our condensed consolidated financial statements for further details regarding our stock-based compensation awards.

Pension and Postretirement Service Costs - SPX FLOW sponsors a number of defined benefit pension plans and a postretirement plan. For all of these plans, changes in the fair value of plan assets and actuarial gains and losses are recognized to earnings in the fourth quarter of each year as a component of net periodic benefit expense, unless earlier remeasurement is required. The remaining components of pension and postretirement expense, primarily service and interest costs and expected return on plan assets, are recorded on a quarterly basis. Non-service-related pension and postretirement costs are reported in “Other income, net.”

    See Note 9 to our condensed consolidated financial statements for further details regarding our pension and postretirement plans.

41

LIQUIDITY AND FINANCIAL CONDITION

Listed below are the cash flows from (used in) operating, investing and financing activities, as well as the net change in cash, cash equivalents and restricted cash, for the six months ended July 3, 2021 and June 27, 2020.

Cash Flow

	Six months ended
	July 3, 2021		June 27, 2020
Cash flows from (used in) continuing operations:
Cash flows from (used in) operating activities	$	33.9	$	(7.5)
Cash flows used in investing activities	(116.4)		(11.6)
Cash flows used in financing activities	(26.0)		(19.3)
Cash flows from (used in) discontinued operations	(0.7)		386.7
Change in cash, cash equivalents and restricted cash due to changes in foreign currency exchange rates	(8.2)		5.4
Net change in cash, cash equivalents and restricted cash	$	(117.4)	$	353.7

Operating Activities - During the six months ended July 3, 2021, the increase in cash flows from operating activities, compared to the same period in 2020, was primarily attributable to increased cash flows from higher segment income and the effects of improvements in working capital management realized during the 2021 period.

Investing Activities - During the six months ended July 3, 2021, such cash flows were comprised primarily of cash paid for the acquisitions of UTG Mixing Group and Philadelphia Mixing and, to a lesser extent, capital expenditures associated generally with the upgrades of manufacturing facilities and information technology. Cash flows for the six months ended June 27, 2020, were comprised primarily of capital expenditures associated generally with the upgrades of manufacturing facilities and information technology.

Financing Activities - During the six months ended July 3, 2021, cash flows used in financing activities related primarily to (i) purchases of common stock of $34.5 associated with a written trading plan under Rule 10b5-1(c) of the Securities and Exchange Act of 1934, as amended, and (ii) payments of minimum withholdings on behalf of employees in connection with net share settlements of $6.3, partially offset by (iii) proceeds received from the exercise of employee stock options of $17.6. During the six months ended June 27, 2020, cash flows used in financing activities related primarily to payments of minimum withholdings on behalf of employees in connection with net share settlements of $6.8, purchases of common stock of $6.2 associated with the written trading plan noted above, and net repayments of purchase card program debt of $4.8.

Discontinued Operations - During the six months ended June 27, 2020, cash flows from discontinued operations consisted primarily of proceeds from the disposition of the Disposal Group of $406.2, less cash and restricted cash disposed of $7.3, net cash used in operating activities of discontinued operations of $6.4 primarily related to the payment of professional fees associated with the disposition during the second quarter of 2020, and capital expenditures during the first quarter of 2020 of $5.5 related to the Disposal Group.

Change in Cash, Cash Equivalents and Restricted Cash due to Changes in Foreign Currency Exchange Rates - The increase (decrease) in cash, cash equivalents and restricted cash due to changes in foreign currency exchange rates of $(8.2) and $5.4, respectively, in the six months ended July 3, 2021 and June 27, 2020, reflected primarily an increase (decrease) in U.S dollar equivalent balances of foreign-denominated cash, cash equivalents and restricted cash as a result of changes in the U.S. dollar against various foreign currencies during the respective periods.

42

Borrowings and Availability

Borrowings —Debt at July 3, 2021 and December 31, 2020 was comprised of the following:

	July 3, 2021		December 31, 2020
Term loan, due in June 2022	$	100.0	$	100.0
5.875% senior notes, due in August 2026	300.0		300.0
Other indebtedness(1)	16.0		13.0
Less: deferred financing fees(2)	(2.8)		(3.1)
Total debt	413.2		409.9
Less: short-term debt	15.5		12.5
Less: current maturities of long-term debt	0.1		0.1
Total long-term debt	$	397.6	$	397.3

(1)Primarily includes finance lease obligations of $0.5 and $0.5 and balances under a purchase card program of $15.3 and $12.5 as of July 3, 2021 and December 31, 2020, respectively. The purchase card program allows for payment beyond customary payment terms for goods and services acquired under the program. As this arrangement extends the payment of these purchases beyond their normal payment terms through third-party lending institutions, we have classified these amounts as short-term debt.

(2)Deferred financing fees were comprised of fees related to the term loan and senior notes.

    Availability — At July 3, 2021, we had $494.7 of borrowing capacity under our revolving credit facilities after giving effect to $5.3 reserved for outstanding letters of credit. In addition, at July 3, 2021, we had $98.8 of available issuance capacity under our foreign credit instrument facilities after giving effect to $51.2 reserved for outstanding bank guarantees. In addition, we had $2.1 of bank guarantees outstanding under the senior credit facilities that, once satisfied, cannot be reissued.

At July 3, 2021, in addition to the revolving lines of credit described above, we had approximately $6.0 of letters of credit outstanding under separate arrangements in China and India.

    Refer to Note 10 for further information on our borrowings as of July 3, 2021.

    At July 3, 2021, we were in compliance with all covenants of our senior credit facilities and senior notes.

See Note 16 to our accompanying condensed consolidated financial statements for information regarding certain subsequent events impacting the Company's indebtedness, including (i) our notification to bondholders of our irrevocable intent to redeem the full principal amount of our senior notes during the third quarter of 2021, and (ii) an amendment to our senior credit facilities executed during the third quarter of 2021.

Financial Instruments

We measure our financial assets and liabilities on a recurring basis, and nonfinancial assets and liabilities on a non-recurring basis, at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We utilize market data or assumptions that we believe market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).

Our derivative financial assets and liabilities include FX forward contracts and FX embedded derivatives measured at fair value using observable market inputs such as forward rates, interest rates, our own credit risk and our counterparties' credit risks. Based on these inputs, the derivative assets and liabilities are classified within Level 2 of the valuation hierarchy. Based on our continued ability to enter into forward contracts, we consider the markets for our fair value instruments active.

As of July 3, 2021, there had been no significant impact to the fair value of our derivative liabilities due to our own credit risk as the related instruments were collateralized under our senior credit facilities. Similarly, there had been no significant impact to the fair value of our derivative assets based on our evaluation of our counterparties' credit risks.

43

We primarily use the income approach, market approach, or both approaches, as appropriate. The income approach uses valuation techniques to convert future amounts to a single present amount. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. Assets and liabilities measured at fair value on a recurring basis are further discussed below.

Currency Forward Contracts and Currency Forward Embedded Derivatives

We manufacture and sell our products in a number of countries and, as a result, are exposed to movements in foreign currency exchange rates. Our objective is to preserve the economic value of non-functional currency-denominated cash flows and to minimize the impact of changes as a result of currency fluctuations (see Note 11 to our condensed consolidated financial statements). Our principal currency exposures relate to the Euro, Chinese Yuan and British Pound.

We had FX forward contracts with an aggregate notional amount of $34.3 and $40.7 outstanding as of July 3, 2021 and December 31, 2020, respectively, with all such contracts scheduled to mature within one year. We also had FX embedded derivatives with an aggregate notional amount of $0.2 and $5.5 at July 3, 2021 and December 31, 2020, respectively, with all such contracts scheduled to mature within one year. There were no unrealized gains or losses recorded in accumulated other comprehensive loss related to FX forward contracts as of July 3, 2021 and December 31, 2020, respectively. The net losses recorded in “Other income, net” related to FX losses totaled $0.5 and $1.0 for the three months ended July 3, 2021 and June 27, 2020, respectively, and $0.6 and $1.8 for the six months then ended.

The net fair values of our FX forward contracts and FX embedded derivatives were $0.0 and $0.2 (assets) at July 3, 2021 and December 31, 2020, respectively.

Other Fair Value Financial Assets and Liabilities

The carrying amounts of cash and equivalents, receivables and contract assets reported in our condensed consolidated balance sheets approximate fair value due to the short-term nature of those instruments.

The fair value of our debt instruments (excluding finance leases and deferred financing fees), based on borrowing rates available to us at July 3, 2021 for similar debt, was $425.3, compared to our carrying value of $415.5.

Concentrations of Credit Risk

Financial instruments that potentially subject us to significant concentrations of credit risk consist of cash and equivalents, trade accounts receivable, contract assets and FX forward contracts. These financial instruments, other than trade accounts receivable and contract assets, are placed with high-quality financial institutions throughout the world. We periodically evaluate the credit standing of these financial institutions.

We maintain cash levels in bank accounts that, at times, may exceed federally-insured limits. We have not experienced, and believe we are not exposed to significant risk of, loss in these accounts.

We have credit loss exposure in the event of nonperformance by counterparties to the above financial instruments, but have no other off-balance-sheet credit risk of accounting loss. Except as is provided for in our accompanying condensed consolidated balance sheets through an allowance for uncollectible accounts for certain accounts receivable, we anticipate that counterparties will be able to fully satisfy their obligations under the contracts. We do not obtain collateral or other security to support financial instruments subject to credit risk, but we do monitor the credit standing of counterparties.

Concentrations of credit risk arising from trade accounts receivable and contract assets are due to selling to customers in a particular industry. Credit risks are mitigated by performing ongoing credit evaluations of our customers' financial conditions and obtaining collateral, advance payments, or other security when appropriate. No one customer, or group of customers that, to our knowledge, are under common control, accounted for more than 10% of our revenues for any period presented.

Other Matters

Contractual Obligations - As of July 3, 2021, there were no material changes in our contractual obligations from those disclosed in our 2020 Annual Report on Form 10-K.

44

Our total net liabilities for unrecognized tax benefits including interest were $17.1 as of July 3, 2021. Of that amount, we believe that within the next 12 months it is reasonably possible that our previously unrecognized tax benefits (including interest) could decrease by $0.5 to $1.0.

Contingencies and Other Matters - Various claims, complaints and proceedings arising in the ordinary course of business, including those relating to litigation matters (e.g., class actions, derivative lawsuits and contracts, intellectual property and competitive claims, and claims to certain indemnification obligations arising from previous acquisitions/dispositions), have been filed or are pending against us and certain of our subsidiaries. We believe these matters are either without merit or of a kind that should not have a material effect, individually or in the aggregate, on our financial position, results of operations or cash flows.

We are subject to domestic and international environmental protection laws and regulations with respect to our business operations and are operating in compliance with, or taking action aimed at ensuring compliance with, these laws and regulations. None of our compliance obligations with environmental protection laws and regulations, individually or in the aggregate, is expected to have a material adverse effect on our financial position, results of operations or cash flows.

Refer to Note 13 for discussion regarding amounts reported in “Mezzanine equity” on the condensed consolidated balance sheets as of July 3, 2021 and December 31, 2020 including discussion regarding the exercise of certain put options by a noncontrolling interest shareholder and an agreement reached with such shareholder during the year ended December 31, 2020 related to the Company's purchase of the shareholder's noncontrolling interest in the relevant subsidiary.

General - The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. The accounting policies that we believe are most critical to the portrayal of our financial condition and results of operations and that require our most difficult, subjective or complex judgments in estimating the effect of inherent uncertainties are discussed in our consolidated financial statements included in our 2020 Annual Report on Form 10-K.

45

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

We are exposed to market risk related to changes in interest rates, foreign currency exchange rates and commodity raw material prices, and we selectively use financial instruments to manage certain of these risks. We do not enter into financial instruments for speculative or trading purposes; however, these instruments may be deemed speculative if the future cash flows originally hedged are no longer probable of occurring as anticipated. Our currency exposures vary, but are primarily concentrated in the Euro, Chinese Yuan and British Pound. We generally do not hedge currency translation exposures. Our exposures for commodity raw materials vary, with the highest concentration relating to steel. See Note 11 to our condensed consolidated financial statements for further details.

The following table provides information, as of July 3, 2021, about our primary outstanding debt obligations and presents principal cash flows by contractual maturity dates, weighted-average interest rates and fair values.

	Due Within 1 Year		Due Within 2 Years		Due Within 3 Years		Due Within 4 Years		Due Within 5 Years		Thereafter		Total			Fair Value
Term loan(1)	$	100.0	$	—	$	—	$	—	$	—	$	—	$	100.0		$	100.0
Average interest rate													1.457		%
5.875% senior notes(1)	—		—		—		—		—		300.0		300.0			309.8
Average interest rate													5.875		%

(1)    See Note 16 to our accompanying condensed consolidated financial statements for information regarding certain subsequent events impacting the Company's indebtedness, including (i) our notification to bondholders of our irrevocable intent to redeem the full principal amount of our senior notes during the third quarter of 2021, and (ii) an amendment to our senior credit facilities executed during the third quarter of 2021.

We believe that cash and equivalents, cash flows from operations, and availability under revolving credit facilities will be sufficient to fund working capital needs, planned capital expenditures, dividend payments, other operational cash requirements and required debt service obligations for at least the next 12 months.

We had FX forward contracts with an aggregate notional amount of $34.3 outstanding as of July 3, 2021, with all such contracts scheduled to mature within one year. We also had FX embedded derivatives with an aggregate notional amount of $0.2 at July 3, 2021, with all such contracts scheduled to mature within one year. The gross fair values of our FX forward contracts and FX embedded derivatives, in aggregate, were $0.0 (gross assets) and $0.0 (gross liabilities) as of July 3, 2021.

ITEM 4. Controls and Procedures

SPX FLOW management, including the Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of disclosure controls and procedures, pursuant to Exchange Act Rules 13a-15 and 15d-15, as of July 3, 2021. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of July 3, 2021.

No changes during the quarter ended July 3, 2021 were identified that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting. We have not experienced any material impact to our internal controls over financial reporting despite many of our employees who are responsible for executing and administering such internal controls working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the effects of the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

46

PART II—OTHER INFORMATION

ITEM 1. Legal Proceedings

The information required by this Item is incorporated by reference from the footnotes to the condensed consolidated financial statements, specifically Note 13, “Litigation, Contingent Liabilities and Other Matters,” included under Part I of this Form 10-Q.

ITEM 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in Part I, “Item 1A. Risk Factors” in our 2020 Annual Report on Form 10-K, which could materially affect our business, financial condition, future results of operations or cash flows.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds (in millions, except share and per share amounts, unless otherwise noted)

Issuer Purchases of Equity Securities

    The following table summarizes the repurchases of common stock during the three months ended July 3, 2021:

Period	Total Number of Shares Purchased(1)	Average Price Per Share		Total Number of Shares Purchased as Part of a Publicly Announced Plan or Program(2)	Maximum Approximate Dollar Value of Shares That May Yet be Purchased Under the Plan or Program(2)
4/4/21 - 4/30/21	128,620	$	65.51	128,216	$111.8
5/1/21 - 5/31/21	88,100	$	68.25	84,305	$106.0
6/1/21 - 7/3/21	162,882	$	65.16	160,255	$95.6
Total	379,602	$	66.00	372,776	$95.6

(1)Includes shares of common stock surrendered to us to satisfy tax withholding obligations in connection with the vesting of restricted stock shares and restricted stock units of 404 shares in the period from April 4, 2021 to April 30, 2021, 3,795 shares in May 2021 and 2,627 shares in the period from June 1, 2021 to July 3, 2021.

(2)On March 30, 2020, we announced that our Board of Directors had authorized the Company to repurchase shares of our common stock up to $150 million over a period expiring at the earlier of December 31, 2021 or such earlier time determined by our Board of Directors in its sole discretion.

ITEM 6. Exhibits

Item No.	Description
2.1	Purchase and Sale Agreement dated as of November 24, 2019 between SPX FLOW, Inc. and Boardwalk Parent LLC, incorporated by reference from the Company’s Current Report on Form 8-K filed on November 25, 2019 (file no. 1-37393).
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in the Interactive Data Files submitted as Exhibits 101.*)

47

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		SPX FLOW, Inc.
		(Registrant)
Date: August 4, 2021	By		/s/ Marcus G. Michael
			President and Chief Executive Officer
Date: August 4, 2021	By		/s/ Jaime M. Easley
			Vice President, Chief Financial Officer and Chief Accounting Officer

48